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Body dysmorphic disorder (BDD), a psychological disorder characterized 
by an intense preoccupation with an imagined physical defect, causes extreme 
distress and leads to depression, divorce, and suicide. Currently, empirically- 
supported treatments include cognitive-behavioral therapy (CBT) and selective 
serotonin-reuptake inhibitors, however, one important component of treatment 
literature yet to be investigated is the relative efficacy of cognitive or behavior 
therapy as a sole treatment. In particular, examinations of change processes 
throughout the course of treatment are needed. Thus, the identification of 
necessary treatment components in the CBT package and the isolation of 
specific change processes could lead to a more streamlined and effective 
treatment approach. 
The current study utilized a multiple baseline, treatment crossover design 
to investigate change processes during either behavior therapy (BT) or cognitive 
therapy (CT) for BDD. Following a diagnostic assessment including a semi- 
structured interview for BDD, six individuals diagnosed with the disorder were 
invited to participate, five of whom completed the study. Participants received 
eight sessions of either BT or CT, followed by the same number of sessions of 
the remaining treatment. BT involved exposure with response prevention (ERP), 
and required the completion of ERP exercises both at home and in session. CT 
sessions followed Beck's (I 967, 1976) approach, and involved the identification 
and challenging of cognitive distortions. In addition to a battery of self-report 
questionnaires administered at each phase change and at follow-up, daily 
recordings of compulsive behaviors, appearance-related self-statements, and 
global distress were gathered, as well as weekly third party assessments of 
behavior. 
Visual analysis of daily recordings demonstrated improvement for three of 
the five participants, with behavior therapy appearing to be most effective in 
reducing daily BDD symptoms. In addition, following completion of both cognitive 
and behavioral treatments, three of the five participants met criteria for clinically 
significant improvement on self-report measures of BDD symptoms and 
depression. Finally, investigation into the covariation of BDD-related thoughts 
and behaviors revealed results for two participants. Discussion focused on 
implications for behavioral and cognitive theories of symptom maintenance, as 
well as on interpreting current findings within the body of BDD outcome literature 
and further clinical implications. 
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Chapter 1 
INTRODUCTION 
Body dysmorphic disorder (BDD) is a chronic, debilitating disorder 
characterized by extreme preoccupation with a perceived physical 
abnormality. The defect in appearance is imagined, or if a slight physical 
anomaly is present, an individual's concern is grossly exaggerated 
(American Psychiatric Association [APA], 1994). Clients with BDD are 
intensely preoccupied with their perceived defect and spend hours each 
day ruminating and worrying about it. They believe their defect to be so 
disgusting that others will find them repulsive. In response to these 
obsessions, individuals with BDD also spend hours in compulsive 
checking or other ritualized behaviors in a futile attempt to alleviate the 
discomfort caused by those ruminations (APA, 1994). These rituals are 
very difficult to resist and are distressing, even though the goal of the 
behavior is to reduce the discomfort elicited by the ruminations. Such 
debilitating symptoms may cause extreme distress and can result in 
divorce, job loss, drastic cosmetic surgery, self-mutilation, and even 
suicide (Hollander, Cohen, & Simeon, 1993; Phillips, 1991 ; Phillips, 
1996a, Phillips 2000a, Sobanski & Schmidt, 2000a). 
The area of concern can include any possible body part and 
complaints range from specific (e.g., crooked nose) to vague areas (e.g., 
paleness of the skin). However, some areas of concern are more 
common than others. For example, individuals often worry about the 
shape, size, or symmetry of facial parts (e.g., nose, teeth, chin, eyes, 
mouth, cheeks, or eyebrows). In a British sample of 50 individuals 
diagnosed with BDD, 86% were preoccupied with an aspect of their face 
(Veale, Gournay, Dryden, Boocock, Shah et al., 1996). Other common 
areas include legs, hands, genitals, feet, and shoulders (Sobanski & 
Schmidt, 2000a & b). Many clients also present with imagined flaws in the 
skin or complexion (e.g., scars, wrinkles, paleness or redness of the skin) 
and with the hair (e.g., thinning hair, abnormally shaped hairline, or 
excessive growth of body hair) (Neziroglu & Yaryura-Tobias, 1993a; 
Yaryura-Tobias & Neziroglu, 1997a; Phillips, 1996a; Phillips, McElroy, 
Kecks, Pope, & Hudson, 1993). 
Individuals with BDD experience significant distress over their 
supposed deformity and often describe their preoccupations as 
"tormenting" and "torturous" (Phillips, 1991, p.1140). The obsessions are 
difficult to control and sufferers usually make no attempt to resist them. 
Therefore, clients spend many hours a day obsessing about their defects 
to the extent that the thoughts dominate their lives (APA, 1994). 
lndividuals with severe cases may not leave their homes for fear of being 
seen or may leave only at night. Thus, avoidance of usual activities often 
leads to extreme isolation and impairment in occupational and social 
functioning. 
Those who suffer with BDD characteristically perform compulsive, 
ritualistic behaviors driven by their obsessions and the need to reduce 
their distress. Checking the defect in a mirror and other reflective 
surfaces (e.g., store windows, car bumpers) is a common behavior and 
can consume many hours of the day. Special lighting or magnifying 
glasses sometimes are used to better scrutinize the flaw (APA, 1994). 
Others compulsively avoid mirrors by covering them up, removing them 
from their homes, or only using a bathroom mirror when it is covered with 
steam from the shower (Phillips, 1996a). In addition, excessive grooming 
behavior is common, in which individuals excessively comb hair, pick skin, 
and remove hair, or ritualistically apply makeup. BDD sufferers 
concerned with symmetry of body parts may also measure the flaw 
compulsively (Thorpe & Olson, 1997). These behaviors are completed 
with the goal of reducing distress but they serve to increase the intensity 
of the preoccupation and related anxiety and depression. The negative 
affect that follows BDD rituals is contrary to the rituals of obsessive- 
compulsive disorder, in which sufferers gain momentary relief from the 
completion of a compulsion. 
Muscle dysmorphia has recently been recognized as a subtype of 
BDD (Pope, Gruber, Choi, Olivardia, & Phillips, 1997). Muscle 
dysmorphia is characterized by an intense preoccupation with appearing 
insufficiently muscular. Objectively, individuals with muscle dysmorphia 
are extremely muscular, yet, they perceive themselves to be small or 
skinny. Due to their embarrassment about physical appearance, these 
individuals often engage in compulsive weightlifting for hours a day, often 
in secret. Sufferers often eat large amounts of food, take anabolic 
steroids, and wear several layers of clothing in an attempt to appear larger 
(Phillips, 1999a; Phillips, O'Sullivan, & Pope, 1997). Like those with 
typical BDD, individuals with muscle dysmorphia avoid situations in which 
their bodies may be seen (e.g., beaches, locker rooms, swimming pools). 
In addition, they may engage in compulsive mirror-checking, reassurance- 
seeking, and body-camouflaging. Social, occupational, and interpersonal 
functioning often is impaired due to embarrassment and time-consuming 
workout regimens. 
Muscle dysmorphia is found in both males and females, and is 
particularly prevalent in the professional bodybuilding population (Pope et 
al., 1997). However, the disorder should not be confused with normal 
interest in bodybuilding, which does not cause distress or impairment in 
functioning. Muscle dysmorphia has been referred to as 'reverse 
anorexia', and has been considered as a form of eating disorder because 
of the concern about overall body shape, abnormal eating patterns, and 
excessive exercise (Pope, Katz, & Hudson, 1993). However, muscle 
dysmorphia differs from anorexia nervosa in that individuals are primarily 
concerned with increasing body mass, and the primary focus lies with 
exercise instead of diet. At the present time, the conceptualization of 
muscle dysmorphia as a subtype of BDD is thought to be the most 
appropriate (Phillips, 1999a). The disorder has phenomenological 
similarities to BDD and responds to exposure with response prevention 
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techniques similar to those utilized in the treatment of BDD. Research on 
muscle dysmorphia is extremely preliminary however, and more 
investigation is needed. 
Because BDD is such a debilitating disorder, research on effective 
treatment remains of critical importance. Currently, the outcome literature 
for BDD is sparse but is increasing in size and improving in 
methodological rigor. Initial reports of treatment success consisted of 
case studies and pre-post measurements of symptom severity (Marks & 
Mishan, 1988; Munjack, 1978). More recent studies have exercised 
greater methodological control through random assignment to groups and 
comparisons to no-treatment controls (Rosen, Reiter, & Oronson, 1995; 
Veale et al, 1996). However, in all but one of these outcome studies, the 
treatment involves a package treatment of cognitive and behavioral 
techniques. No published studies have examined the relative 
effectiveness of cognitive challenging versus exposure with response 
prevention. In addition, although a cognitive-behavioral theory of BDD 
has been proposed, no experimental testing has been conducted. 
Thus, the current body of BDD literature is lacking a test of the 
etiological and maintenance theories of the disorder. Although some 
information exists regarding the combined effects of cognitive and 
behavior therapies, we have very little knowledge regarding the essential 
components of that treatment package. In addition, there is little 
information on the effect of either behavior therapy (BT) or cognitive 
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therapy (CT) on changing both thoughts and behaviors related to BDD 
concerns. As will be discussed, both behavioral and cognitive theories of 
BDD hypothesize that successful treatment would have positive 
ramifications in both cognitive and behavioral realms. Therefore, an 
investigation into the processes of change during behavior and cognitive 
therapies would provide information regarding the utility of each individual 
treatment. To address this need, the current study examines the separate 
effects of behavioral and cognitive interventions on changes in BDD- 
related cognitions and behaviors. Using a multiple baseline crossover 
design, behavioral and cognitive theories of symptom maintenance will be 
investigated by examining the effects of exposure with response 
prevention and of altering maladaptive cognitive processes. 
Histow and Demographics 
BDD was initially described in the literature in the late 19th/early 
20th centuries (Janet, 1903, as cited in Hay, 1970; Morselli, 1891 as cited 
in Hay, 1970). Morselli used the term 'dysmorphophobia' to describe a 
subjective feeling of physical deformity or ugliness in normally-appearing 
individuals. The term comes from the Greek word 'dysmorphia', which 
means abnormal shape (Yaryura-Tobias & Neziroglu, 1997b). 
Dysmorphophobia has been recategorized several times throughout the 
history of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM). In the DSM-Ill (APA, 1980) it was categorized as 'Atypical 
somatoform disorder', and divided in the DSM-Ill-R (APA, 1987) into 
'Delusional disorder, somatic subtype', or 'Body dysmorphic disorder', 
depending on the delusionality of the preoccupation. The DSM-IV (APA, 
1994) kept this distinction, but allowed for a simultaneous diagnosis of 
both BDD and delusional disorder in instances where preoccupations are 
of delusional quality. 
lndividuals with BDD usually are diagnosed in late adolescence or 
early twenties (Phillips, 1 996a; Veale et al., 1 996), with males and 
females being equally likely to suffer with the disorder (Phillips, 1996a). 
Individuals with BDD are estimated to comprise 0.7% (Otto, Wilhelm, 
Cohen, & Harlow, 2001) to 2% of the population (Hollander & Wong, 
1995). However, these prevalence rates are thought to be an 
underestimate as many sufferers of BDD present to dermatologists and 
plastic surgeons rather than to mental health professionals. Many 
individuals with BDD also go undiagnosed due to extreme 
embarrassment. For example, Phillips (1 991 ) reported treating a 
depressed client for two years before the client disclosed BDD symptoms. 
The client was so ashamed of his supposed physical defect that he 
stated, "I didn't have the guts to talk about it" (Phillips, 1991, p.1147). In 
addition, individuals with BDD tend to present with other disorders (e.g., 
depression, social phobia, obsessive-compulsive disorder), thereby 
receiving diagnosis and treatment separate from BDD (Grant, Kim, & 
Crow, 2001 ; Hollander, Neville, Frenkle, & Josephson, 1992). 
Differential Diaqnosis and Comorbidity 
Considering that 50 to 70% of the general population report overall 
body dissatisfaction, the appearance preoccupations of BDD must be 
differentiated from everyday, normal concerns about how individuals look 
(Biby, 1998; Castelnuevo-Tedesco, 1992). As opposed to standard 
appearance concerns, the negative thoughts about appearance 
demonstrated in BDD are extremely difficult to resist and often intrude on 
other thoughts and cognitive processes. The preoccupations are time- 
consuming, occupying several hours a day. In addition, individuals with 
BDD spend significant amounts of time in repetitive, ritualistic behaviors. 
Many avoid social situations or other events in which evaluation of 
appearance may occur (APA, 1994). Sufferers hold onto their distorted 
beliefs in the face of disputing evidence, and they may be convinced that 
their defects warrant medical attention or cosmetic surgery. The 
appearance concerns of the general population do not cause the same 
amount of persistent, all-encompassing distress nor significant impairment 
in functioning (Castelnuevo-Tedesco, 1992). Although there is evidence 
of distorted appearance-related thinking patterns in the general population 
(Mable, Balance, Galgan, 1986), the difference between clinical and 
nonclinical distress may lie in the distinction between body dissatisfaction 
and body distortion. 
The presentation of BDD symptoms also resembles that of 
anorexia nervosa (AN). Currently, the diagnoses of BDD and AN are 
exclusionary, in that the DSM-IV (APA, 1994) excludes a diagnosis of 
BDD in the presence of abnormal eating habits. However, there are many 
phenomenological similarities between the two disorders. In both BDD 
and AN, individuals hold a distorted perception of their appearance. 
Along with this distorted view, both disorders are characterized by intense 
preoccupations with physical appearance and compulsive behaviors (e.g., 
mirror-checking in BDD; weighing in AN). Both disorders involve an 
overemphasis on the importance of appearance for self-worth and 
relationships. Individuals with BDD or AN characteristically avoid social 
situations, certain types of clothing, and other activities that result in self- 
consciousness. In addition, emphasis on beauty remedies is focal in both 
disorders (Rosen & Ramirez, 1998). The presentation of body 
dissatisfaction is so similar between AN and BDD that eating disorders 
have been assessed using BDD measures (Rosen, Reiter, & Oronsan, 
1994). 
Despite the above similarities, there are many factors that separate 
BDD from AN. The focus of preoccupations in AN is an intense fear of 
gaining weight accompanied by a refusal to maintain a body weight over 
the minimal normal weight for age and height (APA, 1994). In AN, the 
overall body image is distorted, however, in BDD the appearance defect 
can include any conceivable body part, and is not restricted to size or 
weight. Individuals with BDD may have a severely distorted image of a 
particular aspect of their appearance, yet a completely rational view of the 
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rest of their body. In addition, BDD and AN differ in that people with AN 
often blame themselves for their weight, believing that their size is due to 
their gluttony and lack of willpower (Rosen & Ramirez, 1998). On the 
other hand, those with BDD usually see their defects as inherited traits or 
flaws with which they were born. In a study comparing BDD and eating 
disorders (Rosen & Ramirez, 1998) both groups demonstrated equally 
severe disturbances in body image that were significantly greater than the 
disturbance of a control group. However, individuals with eating disorders 
were more concerned with the size and shape of large body regions, and 
those with BDD were preoccupied with more specific areas of their 
bodies. Both clinical groups, however, reported similar low levels of self- 
esteem. Cororve and Gleaves (2001) suggest that the gender differential 
between BDD and AN could potentially be explained by cultural factors, 
with intense pressures for thinness in women versus more broad 
definitions for attractiveness in men. 
BDD often is associated with major depressive disorder (APA, 
1994). Low self-esteem and depressive symptoms often co-occur with 
appearance dissatisfaction (Grubb, Sellars, & Waligroski, 1993; Mable et 
al., 1986), and the rate of co-existing depression and BDD can be as high 
as 82% (Phillips & Diaz, 1997). However, it is unclear whether depression 
is a result of the body dissatisfaction and isolation of BDD or if it is an 
etiological factor (Biby, 1998). Yaryura-Tobias and Neziroglu (1 997a) 
suggest that depression develops as a secondary or reactive depression 
because of the disruption in social, occupational, and interpersonal 
functioning. Phillips (1 999b) proposes that BDD-related depression is 
heterogeneous in nature, allowing a variety of relationships between the 
two disorders. In this context, depression could be either secondary to or 
independent of BDD, or the disorders may both lie on an affective 
spectrum of pathology (Phillips, 1999b). Because sufferers sometimes 
wait for years before seeking psychological assistance, the study of 
depression in individuals with BDD has been hampered. 
Finally, high rates of comorbidity have been demonstrated between 
BDD and personality disorders. An outcome study of 17 individuals 
diagnosed with BDD revealed that the entire sample met criteria for at 
least one personality disorder diagnosis, with 13 meeting criteria for four 
or more (Neziroglu, McKay, Todaro, & Yaryura-Tobias, 1996). The most 
common diagnoses included avoidant, borderline, obsessive-compulsive, 
self-defeating, and dependent. No relationship was demonstrated 
between treatment outcome and number or type of personality diagnosis. 
Further investigations have shown Axis-ll disorders to be prevalent among 
the BDD population. Another study of 17 participants revealed 87% to 
have at least one personality disorder, with a mean of 2.53 Axis-ll 
diagnoses (Cohen, Kingston, Bell, Kwon, Aronowitz, & Hollander, 2000). 
In this study, personality impairment was positively related to 
pharmacological treatment outcome. Another large scale study also 
found that 57% of 74 participants had one or more personality disorders, 
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with the most common being avoidant, dependent, obsessive-compulsive, 
and paranoid (Phillips & McElroy, 2000). Because of the close 
resemblance between avoidant personality disorder criteria and the social 
and interpersonal avoidance integral to BDD, future research should 
identify whether the avoidant behaviors used in making the Axis-ll 
diagnosis are over and above those typically found in BDD. 
Connections Between BDD and Obsessive-Compulsive Disorder 
Obsessive-compulsive disorder (OCD) is a psychological disorder 
characterized by intrusive and unwanted thoughts, ideas, or images that 
lead to an increase in anxiety followed by repetitious, intentional rituals in 
order to neutralize the anxiety (APA, 1994). The obsessive-compulsive 
spectrum represents a set of major disorders that manifest obsessions 
and compulsions of such intensity as to be considered variants of OCD 
(Yaryura-Tobias & Neziroglu, 1997a). Although the DSM-IV currently 
classifies BDD as a somatoform disorder, many investigators in the field 
conceptualize the disorder as part of the obsessive-compulsive (OC) 
spectrum (Cororve & Gleaves, 2001 ; Hollander et al., 1993; Phillips, 
2000b; Yaryura-Tobias & Neziroglu, 1997b). In fact, the connections 
between OCD and BDD are of sufficient magnitude that the psychological 
and pharmacological treatment of BDD has been modeled after that of 
OCD. 
The relation between BDD and OCD may be seen on many levels. 
First, BDD is phenomenologically similar to OCD. The core symptoms of 
BDD resemble those of OCD in that individuals attempt to suppress 
intrusive thoughts that are anxiety-producing, persistent, recurrent, and 
difficult to control (Phillips, et al., 1993). In both disorders, individuals 
perform irresistible compulsions in response to discomfort elicited by the 
obsessions. For example, an OCD sufferer may experience an obsession 
about the harmful nature of germs and respond by repeated and ritualistic 
washing. With BDD, the thought that a pimple causes the person to 
appear disgustingly ugly could lead to ritualistic mirror-checking and skin- 
picking in an attempt to reduce distress and improve the appearance of 
the face. In addition, similarities exist in general obsessional content and 
structure of rituals. For instance, preoccupations in both disorders often 
center around a need for symmetry, perfection, and the sense of being 
"just right", whereas compulsions common to both include checking and 
reassurance-seeking (Phillips, 2000 b). In fact, symptomatology appears 
so similar that BDD is often misdiagnosed as OCD (Vitello & deleon, 
1990). 
Obviously, however, phenomenological differences also exist. The 
specific content of BDD-related obsessions focuses on appearance, 
whereas those of OCD center around other concerns. In addition, BDD 
preoccupations are associated more often with shame, fear of rejection, 
and low self-esteem (Phillips, 2000b), and BDD-related rituals tend to 
increase rather than decrease distress (Neziroglu, 2000). In addition, 
BDD rituals have a somewhat reasonable connection to the content of the 
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preoccupations. For example, the thought that a body part is ugly may 
lead to the examining of that feature in the mirror. In OCD, the content of 
the obsessions often has no logical transition to the coinciding 
compulsions (e.g., counting to 100 in multiples of three in an attempt to 
prevent harm). Finally, level of insight in BDD tends to be more 
compromised, in that delusions of reference and beliefs of delusional or 
overvalued intensity occur more often than with OCD (Phillips, 2000b; 
Simeon, Hollander, Stein, Cohen, & Aronowitz, 1995). 
Both BDD and OCD have similar demographic characteristics, age 
of onset, and course of symptomatology. In a comparison study, the two 
groups were similar on education level, and gender ratio was found to be 
approximately 1:l for both disorders (Phillips, Gunderson, Mallay, 
McElroy, & Carter, 1998). In addition, the onset of both disorders often is 
seen in childhood or early adolescence and, when untreated, typically 
progresses with a chronic course. However, those who suffered with BDD 
were significantly less likely to have been married (Phillips, 2000a). 
BDD and OCD also are highly comorbid with each other and with 
other similar disorders. In a study of 100 BDD clients, 34% also met 
criteria for OCD (Phillips, McElroy, Keck, Hudson, & Pope, 1994), and 
studies of OCD find comorbidity rates of up to 37% for BDD (Hollander et 
al., 1993; Phillips et al., 1998; Simeon, et al., 1995). Both disorders 
generally have similar comorbidity patterns with other disorders, however, 
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individuals with BDD have significantly higher rates of major depression 
and social phobia (Phillips et al., 1998). 
Finally, results of pharmacological studies suggest a relationship 
between BDD and OCD in the preferential responses to selective 
serotonin reuptake inhibitors (SSRls; Phillips, Albertini, Siniscalchi, Khan, 
Robinson, 2001). The possibility of common neurochemical mechanisms 
has been suggested due to the fact that individuals with BDD or OCD who 
are unresponsive to cognitive-behavioral treatment respond positively to 
the same selective serotonin-reuptake inhibitors (Hollander, Leibowitz, 
Winchel, Klumker, & Klein, 1989; Hollander et al., 1993). In addition, 
pharmacological augmentation strategies used for OCD nonresponders 
also have been useful in treating refractory BDD (Phillips, 1996~). 
Although these similarities do not represent definitive evidence, the 
conceptualization of BDD as an OC-spectrum disorder is reasonable. 
Thus, the behavioral theory and treatment of BDD has developed from the 
behavioral model of OCD. 
Behavioral Theory of OCD 
The behavioral conceptualization of OCD is based upon Mowrer's 
two-factor learning theory (Mowrer, 1960), which explains the acquisition 
of general fear and avoidance through the principles of classical and 
operant conditioning. The first stage of this theory (acquisition) postulates 
that fear is acquired through the process of classical conditioning, which 
focuses on the association between a neutral stimulus and a reflexive 
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fearful response. According to conditioning theory, an aversive stimulus 
that automatically precedes an aversive response becomes paired with a 
neutral stimulus. Through this pairing, the neutral stimulus acquires the 
ability to elicit that aversive response. These conditioned stimuli may 
include concrete objects, as well as thoughts and images. The second 
stage (fear maintenance) operates on the reinforcement principles of 
operant conditioning, specifically those of negative reinforcement. With 
negative reinforcement, behaviors are maintained or increased through 
the blocking or avoidance of an aversive stimulus. In OCD, rituals and 
avoidance behaviors are developed and maintained through negative 
reinforcement because they reduce anxiety evoked by the conditioned 
stimulus in stage one (Mowrer, 1960). 
The first fear-acquisition stage of Mowrer's two-factor theory (1 960) 
is not thought to be an adequate explanation for the initial development of 
obsessive fears (Foa & Tillmanns, 1980; Rachman & Shafran, 1998; 
Steketee & Tynes, 1991). During this phase, a previously neutral stimulus 
becomes paired with a stimulus that naturally produces fear, and the 
neutral stimulus then acquires the ability to elicit the fearful response. 
However, many OCD sufferers cannot recall aversive learning events that 
are related thematically to the obsessions or compulsions nor with the 
onset of symptoms (Rachman, & Shafran, 1998; Steketee & Tynes, 
1991). 
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Despite a lack of ability to account for the acquisition of obsessive 
fears, Mowrer's model has been utilized as an explanation of symptom 
maintenance. The application of Mowrer's theory to the behavioral model 
of OCD focuses mainly on the second stage of fear maintenance, which 
adheres to reinforcement principles as an explanation for the 
maintenance of compulsive rituals and avoidance behaviors. In both 
subjective and physiological domains, empirical support for the anxiety- 
reducing properties of compulsions has been demonstrated (Rachman & 
Hodgson, 1980; Rachman, & Shafran, 1998). Thus, OCD has been 
conceptualized in terms of a functional relationship between obsessive- 
compulsive symptoms and anxiety (Foa & Tillmanns, 1980). In other 
words, obsessive thoughts, images, and impulses elicit anxiety, and 
compulsive behaviors are seen as attempts to decrease that anxiety. 
Thus, compulsive rituals are maintained by their negatively reinforcing 
properties, and are performed repeatedly until discomfort has decreased. 
When exposed to a fearful obsession, individuals repeatedly perform 
rituals that artificially and temporarily reduce the discomfort and prevent 
the natural habituation to that stimulus. It is this prevention of the natural 
habituation process that is the target of the currently empirically supported 
behavioral treatment for OCD - exposure with response prevention (ERP). 
ERP involves the repeated exposure to obsessional material and 
the prevention of the ritualized behaviors, in order to disrupt the negatively 
reinforcing properties of the ritual and to allow for extinction of the anxiety 
response (Meyer, 1966). As previously mentioned, rituals are 
conceptualized as a maintaining factor because they prevent the natural 
habituation to discomfort by reducing the distress more rapidly, albeit 
temporarily. Consequently, individuals do not experience the naturally- 
occurring, yet slower, decrease in anxiety that would take place in the 
absence of the ritual. Thus, during ERP, individuals are exposed to the 
anxiety-provoking stimulus so that the ritual prevention component can 
allow for the extinction of the anxiety response. 
Behavioral Theow of BDD. 
Because BDD has been conceptualized as an OC-spectrum 
disorder, Mowrer's two-factor theory may be an appropriate model on 
which to base a behavioral theory of BDD. Indeed, early learning 
experiences have been discussed as precursors in the development of 
BDD symptoms (Rosen et al., 1995). For example, in keeping with the 
classical conditioning model for fear acquisition, humiliating teasing and 
peer rejection may naturally create an anxiety response. Then, events 
involving appearance evaluation become paired with anxiety-provoking 
teasing so that appearance-related thoughts and situations acquire the 
ability to create an anxiety response. 
As possible support for this theory, BDD symptoms often are 
reported to first appear in adolescence, a time during which physical 
differences are especially powerful elicitors of peer attention (Phillips, 
1991 ; Phillips, Atala, & Albertini, 1995; Neziroglu & Yaryura-Tobias, 
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1993a). In addition, Phillips (1 996b) reported several examples in which 
the development of BDD symptoms coincided with negative comments 
about appearance. For example, one client began worrying about his 
appearance when high school friends called him "pizza face" (Phillips, 
1996b, p.186). Following this comment, the client felt extremely self- 
conscious about his skin and began checking his face in the mirror 
several times a day. In another study (O'Grady, Thorpe, & Hecker, 1999), 
a client was able to pinpoint a humiliating experience in late adolescence 
that marked the beginning of obsessions about her feet. Yet another BDD 
sufferer recalled painful teasing about facial ugliness that he associated 
with the onset of BDD symptoms and several suicide attempts (O'Grady, 
Hecker, Thorpe, & Maki, 2001). Thus, for some individuals, negative 
appearance-related learning experiences appear to precede the onset of 
BDD symptoms. 
However, Mowrer's fear acquisition theory currently lacks empirical 
support as an explanation for BDD symptom onset. Research has not 
demonstrated such conditioning events in all BDD sufferers, nor does 
BDD develop in every individual who has been teased about appearance. 
Therefore, at this point in time, classical conditioning events may be seen 
only as a contributing factor to the development of BDD. 
The second component of Mowrer's two-factor theory (fear 
maintenance) may be used to explain the maintenance of BDD rituals and 
avoidance behaviors. Through negative reinforcement, the avoidance 
behaviors are strengthened and the association between the feared 
stimuli and aversive events is maintained. Escape and avoidance 
behaviors prevent the natural habituation to discomfort and, therefore, are 
maintained as the typical fear response (Hodgson & Rachman, 1972; 
Roper, Rachman, & Hodgson, 1973). In the case of BDD, avoidance of 
and escape from social situations are negatively reinforcing because the 
discomfort, embarrassment, and humiliation of exposing the defect is 
avoided or reduced. 
Also hypothesized to be reinforcing, rituals such as mirror-checking 
and reassurance-seeking are thought to provide short-term relief 
(Yaryura-Tobias & Neziroglu, 1997a). Paradoxically, however, individuals 
report an increase in distress both during and after the ritual (Phillips, 
1996b; Veale & Riley, 2001). One explanation for this conflict may be that 
individuals experience a very short period of relief that is reinforcing, only 
to be followed by intense feelings of ugliness, guilt, and shame for 
conducting the ritual. The fleeting relief that follows the ritual may be 
sufficiently reinforcing to maintain the behavior. Rituals also may be 
maintained because the discomfort of not performing the ritual would 
increase to levels even higher than those experienced during ritual. 
Clients have reported strong beliefs and images of ugliness that mount in 
intensity prior to mirror-checking rituals (O'Grady, Thorpe, & Hecker, 
1999). Such reports revealed that the image seen in the mirror is 
perceived as terribly ugly, but not quite as horrendous as the imagined 
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appearance. Thus, although mirror-checking may provide some level of 
reinforcing reassurance, the negative feelings associated with the 
perceived ugliness of the reflection still are intense and distressing. Thus, 
rituals such as mirror-checking and reassurance-seeking create a vicious 
cycle in which attending to anxiety-provoking body parts is both 
reinforcing, yet disturbing. 
One study of mirror-checking compared 52 BDD clients with 55 
controls using a self-report mirror-gazing questionnaire (Veale & Riley, 
2001). Results demonstrated that, prior to checking the mirror, BDD 
clients reported several motivations: the hope that they would look 
different this time, the urge to know exactly how they appeared, the belief 
that they would feel worse if they did not check, and the intention to 
camouflage. BDD clients were more likely than controls to focus on an 
internal feeling rather than specific body parts, to practice a face that they 
would present while in public, and to use "mental cosmetic surgery" to 
change their body image. In addition, those with BDD reported feeling 
worse following the period of mirror-checking. 
As with OCD treatment, ERP exercises conducted in the treatment 
of BDD encourage exposure to anxiety-provoking situations (e.g., 
attending social and public events, exposing the defect to another person) 
and prevention from ritualizing (e.g., dashing from the party, covering the 
defect). The intent of ERP is to allow for the natural habituation to the 
situation and, ultimately, the extinction of the anxiety response. 
Beck's Cognitive Theory 
The cognitive model of BDD follows from Beck's conceptualization 
of depression (Beck, 1963; 1964;1976a), which also has been applied as 
a model for anxiety disorders (Beck, Emery, & Greenberg, 1985). Within 
this model, distorted information processing strategies and dysfunctional 
assumptions about the self, world, and others arise from maladaptive 
cognitive schemas. Thus, cognitive therapy strives to alter unhelpful 
schemas by challenging faulty assumptions and replacing distorted 
cognitive processes with more adaptive strategies. In addition, 
therapeutic cognitive change is thought to produce consequent 
modifications in both behavior and affect. Thus, although thoughts are 
the direct target of cognitive therapy, treatment is believed to have positive 
ramifications on emotions and actions. 
Beck's cognitive model is composed of three concepts: the 
cognitive triad, schemas, and cognitive distortions. The cognitive triad 
represents an idiosyncratic pattern of thought encompassing the self, the 
world, and the future. Negative views of the self lead to unpleasant 
experiences, which are thought to be further evidence of personal defects. 
Then, individuals draw illogical connections between their supposed 
personal flaws and their ultimate character, which may be assumed to be 
worthless and unlovable. In addition, the individual's ongoing experiences 
and the world in general are interpreted as negative. The world is seen as 
making excessive demands, placing unreasonable obstacles throughout 
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daily life. Ongoing interactions with the environment often are negatively 
misconstrued, despite more obvious and positive interpretations. The 
final aspect of the cognitive triad involves a pessimistic view of the future. 
Long-term expectations of life include the continuation of current 
difficulties and the introduction of additional frustrations, hardships, and 
unfair consequences. 
The second component of Beck's cognitive model (Beck, 1963; 
1964; 1976) is the concept of schemas. Schemas are hypothesized 
frameworks that influence the organization of incoming information and 
guide the understanding of life experience (Freeman & Davis, 1990). Any 
given situation may be perceived in multiple ways due to the variety of 
available information. According to cognitive theory, any one individual 
will attend selectively to particular stimuli and organize the information 
according to their own internal framework or schema. The schema is a 
relatively stable structure that allows for consistent responses to similar 
situations, with different schemas hypothesized to be activated in different 
situations. When the situational-specific schema is activated, it guides the 
processing of the event such that environmental stimuli are categorized 
and evaluated in agreement with the schema. An individual then 
responds in a manner congruent with the interpretation. Some schemas 
may be dormant for a period of time and then activated by a specific 
stressful event. Because information is organized to be consonant with 
the activated schema, a dysfunctional schema elicited by a stressful event 
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would organize information in a pathological manner, so that an individual 
selectively attends to negative stimuli. Thus, situations will be 
misinterpreted and information organized in an inappropriate manner and 
with negative content. 
The final component of Beck's model incorporates faulty methods 
of information processing, referred to as cognitive distortions. Cognitive 
distortions are routine errors in thinking that are based on idiosyncratic 
views (Beck 1967, Freeman & ~avis,' 1990). The distortions, which are 
consonant with activated schemas, serve to support an individual's 
negative beliefs even in the presence of contradictory information. For 
example, the distortion referred to as 'selective abstraction' involves 
conceptualizing an entire experience based on a seemingly minor and 
inconsequential detail, while ignoring more salient and pertinent 
information. Another pattern (dichotomous thinking) describes a tendency 
to place all experiences in one of two polarized categories. Thus, through 
the faulty processing and organization of information, cognitive distortions 
are the mechanism through which negative schemas are supported and 
maintained. 
Beck's cognitive therapy follows directly from the above theory. 
According to cognitive theory, the content of underlying schemas is 
reflected in the theme of these cognitive distortions. Therefore, distortions 
become the initial target of treatment as a means of ultimately accessing 
and altering the unhelpful schema. Distortions, in turn, can be accessed 
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through automatic thoughts, which are spontaneous thoughts associated 
with certain situations and mood states (Beck, 1995; Freeman & Davis, 
1990). Therapy involves tracking these spontaneous and automatic 
statements across situations in order to identify the distortions. The 
labeling of distortions allows an individual to understand dysfunctional 
thought patterns and begin to alter them. The ultimate goal of altering 
these patterns is to challenge the underlying maladaptive schema and 
initiate the development of one that is more adaptive. 
Cognitive theory proposes that the most strategic method for 
creating therapeutic change is through altering inner beliefs and thinking 
patterns. Due to the idiosyncratic nature of cognitive processes, each 
individual will perceive, and therefore react, differently in a given situation. 
Thus, the perception of an event, not the event itself, determines the 
consequent emotional reaction. Therefore, according to cognitive theory, 
the most beneficial point of intervention lies with cognitions. Because 
cognitions are believed to be linked with both behavior and affect, a 
change in one component is hypothesized to result in change among the 
others (Beck, 1976; 1996, Freeman & Davis, 1990). Successful cognitive 
therapy should result not only in positive cognitive change, but in 
beneficial modifications in behavior and emotion as well. 
Cognitive Theory of BDD 
The cognitive approach to BDD incorporates Beck's concepts of 
schemas, cognitive distortions, and automatic thoughts. As discussed 
previously, Beck's cognitive theory (1 964, 1976) proposes that an 
individual's perception of events is dictated by an underlying schema, the 
content of which shapes the attitudes and beliefs that influence thought, 
behavior, and affect. According to Beck's theory, schemas develop early 
in life due to learning experiences, and lie dormant until activated by a 
relevant event. Once the schema is activated, perceptions are colored by 
the content of that schema. Thus, an individual with a particular schema 
will process relevant information differently than someone without a 
similar structure and, therefore, emotion and behavior will be influenced 
by the perception of an event rather than the event itself. 
The concept of schemas may be applied to the development of 
BDD. Negative appearance-related experiences have been hypothesized 
to set the stage for distorted assumptions about the normality of 
appearance and for dysfunctional connections between appearance, self- 
worth and acceptance (Rosen et al., 1995). These experiences could be 
conceptualized as precipitating factors in the development of a 
maladaptive schema. Once developed, the schema would influence the 
perception of appearance-related situations. According to Cash and 
Labarge (1 996). 'appearance-schematic' individuals react to and process 
appearance-related stimuli differently than those who are 'aschematic'. 
Individuals schematic for appearance are more invested psychologically in 
their physical presentation because appearance is considered to be an 
index of self-worth and a standard for evaluation. Individuals with BDD 
may have these negative appearance schemas and interpret events 
based on the belief 'I am ugly.' This belief causes an individual to 
respond negatively to beauty-related stimuli, shapes the interpretation of 
appearance-related situations, and influences consequent emotions and 
behaviors (Cash & Labarge, 1996). 
One difficulty with this theory is the inability to explain why some 
individuals develop BDD and others with similar early learning 
experiences (e.g., childhood teasing) do not develop the disorder. 
Perhaps, for some reason, these individuals do not develop maladaptive 
appearance schemas at all despite humiliating childhood experiences. 
Perhaps the maladaptive schema does develop but future buffering 
experiences keep the distress at a subthreshold level. Another possibility 
is that the schema develops but continues to lie dormant. These 
questions remain unanswered. 
In addition to the influence of schemas, other cognitive experiences 
(e.g., cognitive distortions, negative self-statements) are thought to 
maintain BDD symptoms (Geremia, 1997; Rosen, 1995). As discussed 
previously, cognitive distortions are negative thought patterns that arise 
from negative schemas. The distortion is thought to reflect the thematic 
content of the schema. For instance, an 'ugly appearance' schema would 
give rise to cognitive distortions about physical attractiveness. One such 
distortion commonly seen in BDD is referred to as 'all-or-none thinking' 
and involves categorizing experiences in terms of extreme categories 
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(Geremia, 1997). An example of all-or-none thinking in BDD is the belief 'I 
have a pimple, therefore my whole appearance is ruined', or 'if I am not 
physically perfect then I must be ugly.' Another cognitive distortion 
commonly found in BDD is 'disqualifying the positive' in which positive 
experiences are discounted so as not to contradict the negative belief 
(Geremia, 1997). This distortion occurs regularly during repetitive 
reassurance-seeking, during which positive comments about appearance 
are dismissed as sympathetic expressions elicited by the clients' extreme 
ugliness. 
BDD symptoms also may be perpetuated through the rehearsal of 
negative self-statements (Rosen et al., 1995). Statements such as "I am 
ugly and worthless" may be rehearsed to the extent that they become 
believable and automatic. In keeping with Beck's theory, these automatic 
thoughts may be seen as reflections of a maladaptive schema. Thus, 
disconfirming evidence for these statements may be discounted due to 
distorted thinking patterns. 
As discussed earlier, cognitive theory proposes that the most 
effective point of intervention lies with changing accessible thinking 
patterns, with the ultimate goal being to alter the underlying schema. 
Because of the proposed connection among thoughts, emotions, and 
behaviors, altering thinking patterns is believed to result in therapeutic 
changes in all three realms. Therefore, initial goals of cognitive therapy 
for BDD would include identifying and challenging appearance-related 
cognitive distortions through the monitoring of automatic thoughts. 
Therapeutic work at this level would move toward challenging and altering 
maladaptive inner beliefs about the self and connections between 
appearance and worth. As therapeutic cognitive gains were made, 
positive changes in affect and behavior also would be expected. 
Empirical Support for ERP and CT with OCD 
Because BDD is considered to be within the OC-spectrum, results 
of the behavioral and cognitive treatments for OCD could be useful, as 
they may extrapolate to the treatment of BDD. Therefore, the following 
section discusses the empirical evidence for ERP and CT as applied in 
the treatment of OCD. 
Meyer (1966) was the first to implement ERP as a treatment for 
OCD and, since then, it has become the first-line psychological treatment 
(Marks, 1997; Steketee & Tynes, 1991). The efficacy of ERP in reducing 
OCD symptoms has been demonstrated in pre- and post-treatment 
studies (Boersma, Den Hengst, Dekker, & Emmelkamp, 1976; 
Emmelkamp & Kraanen, 1977; Foa & Goldstein, 1978; Foa, Grayson, 
Steketee, Doppelt, Turner, & Latimer, 1983), and in comparison to a 
relaxation-training control (Rachman, Marks, & Hodgson, 1973; Roper, 
Rachman, & Marks, 1975). Foa and colleagues summarized 20 studies of 
ERP treatment for OCD (Foa, Steketee, & Ozarow, 1985). They observed 
that following ERP, 51 % of individuals were either 'symptom free' or 
'much improved', whereas another 39% were 'moderately improved.' 
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Only 10% demonstrated no change. In addition, two reviews of controlled 
studies concluded that OCD symptoms improved more with ERP than with 
SSRls, and that improvements were maintained for years following ERP 
compared to relapse after pharmacotherapy (Abel, 1993; van Balkom, van 
Oppen, Vermeulen, van Dyck, Nauta, & Vorst, 1994). The efficacy of 
ERP has been demonstrated, not only at post-treatment, but also in 
follow-up investigations ranging in time from one to six years following 
treatment (O'Sullivan & Marks, 1990). 
In addition to reducing behavioral rituals, ERP has been 
demonstrated to reduce the frequency of obsessions, as well as the 
distress associated with the obsessions. In one study of 21 participants 
treated with ERP, 12 reported no obsessive symptoms following 
treatment, whereas eight reported mild to moderate obsessions, and one 
remained unchanged (Foa & Goldstein, 1978). Other more recent studies 
also have shown a decrease in obsessions and associated anxiety 
following ERP. For example, one investigation of 46 participants 
demonstrated that reduction in fixity of beliefs (i.e., strength of belief in 
feared consequence as a result of not ritualizing) and increase in 
resistance to obsessions correlated significantly with reductions in 
compulsions (Ito, Araujo, Hemsley, & Marks, 1995). Although obsessions 
did decrease following behavioral treatment, improvement was greater on 
behavioral measures (e.g., frequency of rituals and avoidance behaviors). 
Another study of 41 participants examined the effect of ERP on three 
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measures of cognitive change: (i) strength of belief that consequence of 
not ritualizing will occur, (ii) recognition of absurdity of obsession, and (iii) 
degree of conviction in the face of contradictory evidence (Lelliot, 
Noshirvani, Basoglu, Marks, & Monteiro, 1988). Results indicated that 
decreases in scores on the three cognitive scales correlated significantly 
with decreases in ritual frequency. 
Initial studies of cognitive therapy (CT) alone have provided 
positive results. The first randomized controlled trial of CT for OCD 
compared rational emotive therapy (RET) with ERP (Emmelkamp, Visser 
& Hoekstra, 1988). A total of 18 participants received 10 sessions of 
either treatment. At post-treatment and at a six-month follow up, both 
treatments resulted in significant decreases in obsessive-compulsive 
symptoms, with no significant differences between the efficacy of the two 
therapies. In addition, CT significantly improved depressed affect, but 
ERP did not. Another study compared ERP to the combined effects of 
ERP and CT (Emmelkamp & Beens, 1991). Post-treatment comparisons 
of ERP and RET demonstrated no significant differences on symptom 
improvement. However, adding ERP to RET provided no incremental 
benefit. 
Van Oppen and colleagues conducted the first randomized 
controlled trial evaluating Beck's model of CT for OCD (van Oppen, de 
Haan, van Balkom, Spinhoven, Hoogduin et al., 1995). In this study, 71 
participants were randomly assigned to 16 sessions of either CT or ERP. 
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Overall, results demonstrated that both treatments significantly improved 
OCD symptoms to a similar degree. However, CT showed superior 
efficacy on some measures of OC symptoms and on generalized 
measures of psychological distress. Results supporting the efficacy of 
ERP and CT were discussed in a recent review (Abromowitz, 1997). The 
meta-analysis utilized only studies with direct comparisons of randomly 
assigned groups, and examined comparisons between ERP and 
relaxation training, as well as those between ERP and CT. Although 
effect sizes demonstrated a clear superiority of ERP over relaxation 
training, no significant difference between ERP and CT was found. 
Most recently, Salkovskis' (1996) model has been utilized in the 
comparison of cognitive and cognitive-behavioral group therapies for OCD 
(McLean, Whittal, Thordarson, Taylor, Sochting, Koch, et al., 2001). This study 
of 76 participants compared a CT group and a CBT group to a waitlist control, 
demonstrating that both treatments were superior to the control group on a 
measure of obsessive-compulsive symptoms. In addition, ERP alone was 
marginally more effective at post-treatment than the combined CBT intervention, 
with ERP demonstrating a significantly superior effect at a three-month follow-up. 
Interestingly, only one of seven cognitive measures improved over treatment for 
both the ERP and CBT groups. 
Despite the above findings supporting the efficacy of CT for OCD, some 
investigators propose that evidence is insufficient to draw firm conclusions 
(James & Blackburn, 1995; Stanley & Averill, 1998). Following a review of 
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available studies, James and Blackburn (1 995) state that although preliminary 
results may lead to optimistic conclusions, such judgments are premature. First, 
various forms of CT have been utilized, including Beck's model, Salkovski's 
model, and RET. Therefore, generalized conclusions regarding the efficacy of 
CT cannot be drawn. In addition, some studies incorporate behavioral 
experiments that involve some exposure procedures. Therefore, by adding 
behavioral components to CT, a test of pure cognitive strategies is precluded 
(James & Blackburn, 1995; Stanley & Averill, 1998). Thus, although initial 
results are promising, the current supporting body of literature may best be 
considered preliminary. 
Additional Theories of BDD 
Evolutionarv significance. The theory of evolutionary significance 
discusses the potentially adaptive nature of typical BDD concerns. 
According to the theory, two biological factors are hypothesized to 
contribute to the development of BDD. First, many individuals with BDD 
are concerned with the perfect symmetry of body parts, such as ears, 
eyes, breasts, and legs (Phillips, l996a). Veale and colleagues (1 996) 
hypothesize that this drive for symmetry is innate because symmetrical 
body parts are indicative of biological quality. Thus, biological symmetry 
attracts sexual partners by advertising resistance to developmental 
disruptions. Second, the authors propose that the fear of rejection salient 
in BDD sufferers is an adaptive, innate response as well. Those who are 
rejected by potential mates are less likely to procreate. Therefore, the 
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innate drive to pass on genetic material may foster a fear of rejection as 
an adaptive mechanism. 
Veale and colleagues (1 996) link this evolutionary theory to the 
cognitive theory discussed earlier. Because an increased drive for 
symmetry and fear of rejection are proposed to have evolutionary 
significance, thoughts and behaviors that are consonant with such 
predispositions may be considered adaptive as well. Individuals who are 
strongly predisposed to these factors may be more responsive to cues of 
symmetry or rejection and may develop schemata that increase the risk 
for developing BDD. However, Veale and colleagues do not explain how 
the schemata would develop. Another problem with the theory is that 
there is no viable method of supporting or disconfirming the presence of 
such biological predispositions, other than the presence of the symptoms 
themselves. It could be hypothesized that BDD-related cognitions and 
behaviors are due to certain innate factors gone awry, but there must be a 
way of testing those suppositions before the theory can be supported. At 
this time, the capability of assessing and measuring biological 
predispositions does not exist. Thus, the circular argument remains in 
which predispositions exist because symptoms are present; and the 
symptoms are present due to the predispositions. 
An additional difficulty with this theory is the failure to propose 
causal factors for such extreme development of the predispositions. 
Evolutionary theory focuses on the adaptive significance of hereditary 
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traits and the extinction of maladaptive characteristics. Although a drive 
for symmetrical body parts and a fear of rejection may be beneficial in 
moderation, the preoccupation demonstrated in BDD is disabling in 
intensity. The theory does not propose how adaptive concern about 
physical presentation could develop into pathological obsessions over 
imagined defects. 
Selective attention. According to Veale and colleagues (1 996), 
another maintaining factor is the selective attention of BDD clients to their 
perceived defect. This selective attention results in a heightened 
perception and overly-accurate representation of the flawed feature which, 
in turn, may result in a negative judgment of appearance (Veale et al., 
1996). Jerome (1 992) presents observations consistent with the idea that 
BDD clients selectively overfocus on their imagined defects. Twenty 
cosmetic rhinoplasty patients who met criteria for BDD demonstrated a 
more accurate estimation of nose size than controls. Following surgery, 
however, BDD clients failed to maintain their previous level of accuracy, 
and nose size estimation fell within range of controls. Jerome proposes 
that constant mirror-checking and overfocusing on nose shape and 
dimensions form the basis of their overly accurate estimations of nose 
size. After surgery, heavy bandaging prevents such selective attention 
and results in a more normal estimation. According to Jerome, the 
prevention of such focusing, often achieved by mirror-checking, may 
reduce BDD symptoms. 
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A recent study investigated selective attention and overfocusing in 
BDD sufferers (Deckersbach, Savage, Wilhelm, Buhlmann, Reid, et al., 
1998). This study examined whether clients tended to focus on specific 
details of visual material or to integrate those details into a more global 
picture. BDD clients and matched controls were administered the Rey- 
Osterrieth Complex Figure Test (CFT; Austerity, 1944 as cited in 
Deckersbach et al., 1998), a commonly-used neuropsychological 
measure. The CFT requires the examinee to copy a complex geometric 
figure, and then to draw it from memory. Scores on the CTF provide 
information on the accuracy of copied or recalled elements, and quantifies 
the organization of the figure (i.e., how much participants focused on the 
details while copying the figure). Focusing on details of the figure rather 
than the global picture interferes with reproduction of the figures. 
Interestingly, the performance of individuals with BDD on both the copy 
and recall conditions was significantly impaired compared to controls, 
suggesting a focus on particular details rather than on the global figure. 
Although the BDD group copied the CTF figure as accurately as controls, 
they obtained lower organization scores (i-e., the copied version was 
accurate and complete but the process of construction was disorganized). 
In addition, BDD clients remembered significantly fewer components of 
the design when asked to produce the figure from memory. Therefore, 
Deckersbach and colleagues concluded that individuals with BDD 
encoded an unstructured, piece-by-piece, distorted representation of the 
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CFT into memory, which unlike a structured representation, was difficult to 
reproduce from memory. The authors interpreted these results as 
indicative of selective attention. 
The phenomenon of attentional bias in BDD is intriguing, however, 
current data are based on a small number of individuals. Further 
investigation could utilize more precise measurements of attentional bias 
to address questions concerning individual differences, and the causes 
and consequence of selective attention. 
Psvchodvnamic theorv. According to psychodynamic theory, BDD 
results from the unconscious displacement of sexual or emotional conflict 
(Bloch & Glue, 1988). Preoccupation with the appearance defect, 
therefore, acts as a disguise for the true source of distress. Within the 
psychodynamic interpretation, the body part of concern takes on symbolic 
meaning (Phillippopoulos, 1979). For example, the nose is considered as 
a phallic symbol. Thus, a woman who requests rhinoplasty is interpreted 
as attempting to relieve a conflicted identification with her father in order 
to progress into a more feminine role. However, a man who requests a 
smaller nose is considered to be experiencing latent homosexuality. No 
empirical evidence exists to support the psychodynamic conceptualization 
of BDD. 
Treatment of BDD 
Currently, cognitive-behavioral therapy (CBT) and 
pharmacotherapy with serotonin-reuptake inhibitors are the only 
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treatments for BDD that are empirically supported (Chambless & Hollon, 
1998). Psychodynamic treatments have been documented as well (Bloch 
& Glue, 1988; Philippopoulos, 1979) but reports of success are subjective 
in nature. In addition, one report of eye movement desensitization and 
reprocessing demonstrated a reduction in BDD symptoms (Brown, 
McGoldrich, & Buchanan, 1997). Although CBT is considered to be one 
of the two empirically supported treatments, the study of CBT for BDD is 
in its early stages. There exist only a handful of CBT outcome studies, 
most of which are uncontrolled. In many cases, measures of treatment 
effectiveness are restricted to pre- and post-treatment comparisons. 
In an early case study of a 27-year-old male, the effectiveness of 
behavioral therapy for BDD was reported (Munjack, 1978). Treatment 
consisted of 11 sessions of systematic desensitization to address an 
intense preoccupation with facial redness. Following relaxation training, 
two hierarchies were constructed using fears of scrutiny and verbal 
criticism. During each session, relaxation therapy was followed by 
imaginal exposure of hierarchy items. At post-treatment, the client 
reported being no longer bothered by preoccupations about his red 
complexion. Another early report of behavior therapy discusses the 
inpatient treatment of five individuals who suffered chronically with BDD 
(Marks & Mishan, 1988). These five case reports outline the behavioral 
treatment, which consisted primarily of exposure and response 
prevention. Clients demonstrated a decrease in avoidance behaviors and 
associated anxiety. In addition, the delusional beliefs, previously 
assessed as "unamenable" (p.678). were reported as having weakened or 
disappeared. No cognitive therapy or challenging of those beliefs had 
been conducted. Unfortunately, three of the five clients also had begun 
pharmacotherapy during behavioral treatment; therefore, results cannot 
be attributed solely to psychotherapy. 
More recently, Neziroglu and Yaryura-Tobias (1993b) report the 
use of CBT with five BDD clients. Intensive treatment consisted of four 
weeks of 90-minute sessions, five days a week. The first 60 minutes of 
each session were spent on exposure with response prevention (ERP). 
Cognitive therapy, involving identification and challenging of irrational 
cognitions, was conducted during the remainder of the session. Clients 
were assessed pre- and post- treatment, and at a one-year follow-up 
using the Overvalued Ideation Scale (OW) and the Yale Brown Obsessive 
Compulsive Scale adapted for BDD (YBOCS-BDD). Following CBT, 
clients obtained lower scores on both measures, indicating reductions in 
levels of obsessions and behavior. One drawback, however, is that both 
measures of distress relied on self-report and, therefore, are open to 
subjective interpretation. 
In another study, Neziroglu and colleagues examined the effect of 
CBT and the presence of comorbid personality disorders in 17 participants 
with BDD (Neziroglu, et a]., 1996). As in the above study, treatment 
consisted of daily 90-minute sessions over a four-week period. A 
combination of ERP and challenging of cognitions was implemented. 
Results indicated a statistically and clinically significant decrease in 
intensity and frequency of preoccupations and rituals for 12 of the 17 
participants, based on YBOCS-BDD scores. The entire sample met 
criteria for at least one personality disorder; however, no relationship was 
demonstrated between treatment outcome and number or type of 
personality diagnosis. 
Newell and Shrubb (1994) discuss the successful cognitive- 
behavioral treatment of two female clients who refused to participate in 
exposure treatment. Individual therapy consisted of reverse role-plays, or 
"mock trials", in which the client presented arguments for the 
attractiveness of the body part and the therapist presented evidence 
against that argument. For one client, no other attempt was made to 
challenge cognitions or to encourage exposure, whereas exposure 
exercises were integrated during the latter treatment stages for the 
second individual. Self-rated problem severity and strength of negative 
beliefs decreased dramatically following treatment for both clients. 
Two studies have examined the effects of CBT when conducted in 
a group setting. In one study of 54 women diagnosed with BDD, half 
were randomly assigned to a no-treatment control group, while the 
remainder underwent eight weekly 2-hour sessions of group CBT. Groups 
consisted of four to five clients and one therapist (Rosen et at, 1995). 
Compared to the control group, post-treatment scores for CBT clients 
improved significantly on several measures including the BDDE, YBOCS- 
BDD, and the Body Shape Questionnaire. In addition, the treatment 
group improved significantly over time on each measure, as demonstrated 
by follow-up performance. Clinically significant improvement also was 
demonstrated in that clients no longer met criteria for diagnosis and had 
scores on measures of BDD symptomatology lower than the pretreatment 
score minus two standard errors of measurement. However, as in the 
Neziroglu and Yaryura-Tobias (1 993b) study, all measurements were self- 
report. Wilhelm, Otto, Lohr, and Deckersbach (1999) also have 
demonstrated the effectiveness of group CBT for BDD. Thirteen clients 
were assigned consecutively to small groups that met for 12 weekly 90- 
minute sessions. Compared to pre-treatment assessments, clients 
experienced a significant improvement in BDD symptoms and depression 
levels. Similar results for group CBT also have been demonstrated with a 
Spanish sample (Raich, Soler, & Mora, 1995). According to the above 
studies, CBT administered in group settings appears to be a promising 
format for therapeutic change. 
Finally, two studies have been conducted examining either ERP or 
CT alone. McKay and colleagues examined the effectiveness of ERP in 
the absence of cognitive strategies, as well as the benefits of a 
maintenance program following the completion of treatment (McKay, 
Todaro, Neziroglu, Campisi, Moritz, & Yaryura-Tobias, 1997). Ten 
participants attended ERP sessions five days per week for six weeks. 
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Results demonstrated significant improvements on general measures of 
BDD symptoms, depression, and anxiety. Five of the 10 participants who 
received a maintenance program following treatment demonstrated lower 
levels of general anxiety and depression compared to controls, and all 
individuals remained "symptom free" (p.67) at follow-up. Secondly, 
Geremia (1997) conducted a treatment study utilizing cognitive therapy 
consistent with Beck's (1967) model. Four clients were randomly 
assigned to one of two multiple baseline designs. Condition 1 consisted 
of three weeks of baseline data collection followed by seven weeks of 
cognitive therapy and a five week follow-up assessment. The second 
condition involved five weeks of baseline collection, seven weeks of 
treatment, and a three week follow-up. Results were analyzed using 
techniques specifically designed for single-subject experimental research. 
Three of the four clients demonstrated a significant reduction in 
depression, anxiety, and body dissatisfaction following treatment. 
However, only two of those clients reported a significant reduction in the 
intensity and frequency of BDD-related obsessions and compulsions, as 
evidenced by scores on the YBOCS-BDD. Visual inspection of those 
individual cases demonstrated a very gradual improvement in BDD 
symptoms following cognitive therapy. 
In summary, research has demonstrated that a cognitive-behavioral 
treatment package, administered in individual or group format, decreases 
BDD-related obsessions, behaviors, and negative affect. In addition, 
when treatment consists solely of cognitive therapy, reduction in 
obsessions and compulsions occurs in some individuals. What has not 
been explained, thus far, is why cognitive therapy is successful only in 
some cases. If cognitive therapy is not effective for all individuals, 
perhaps behavior therapy would be a viable alternative; or perhaps a 
combination of cognitive and behavioral techniques is needed in some 
cases. The one study that examined pure behavior therapy demonstrated 
decreases in symptoms for all individuals, however, the measures were 
general in nature and do not provide information on individual differences. 
In short, we do not know what approaches are best with certain 
individuals, or what factors influence the effectiveness of behavioral 
versus cognitive techniques. In addition, there exists little information 
regarding the processes that change during the course of behavior or 
cognitive treatment. The current study investigates these processes of 
change through examining daily changes in BDD-related cognitions and 
behaviors over the course of both behavior and cognitive therapy. 
Methodological Issues 
Single-participant desiqns. In designing the current study, some 
methodological issues required consideration. One such decision 
centered around single-case versus group designs, and the 
appropriateness of each for the current questions under investigation. In 
the literature, discussions regarding the usefulness of single-subject 
designs versus group methodology have examined the relative 
contributions of each and the specific types of information that each 
provides (Barlow & Hersen, 1987; Kazdin, 1982; Lundervold & Bellwood, 
2000; Morgan & Morgan, 2001). While group designs allow for the 
comparative testing of two treatments, single case experimental data 
provide detailed information regarding the processes or mechanisms of 
change during the course of a successful treatment. For many decades, 
single-subject designs have been chosen as a means to investigate 
psychological phenomena preliminary studies (Morgan & Morgan, 2001). 
In fact, Kazdin (1982) has argued that preliminary investigations into 
treatment effectiveness should first utilize single-subject designs and 
focus on the process information that is yielded. Then, only once the 
mechanisms of change have been identified, should group designs be 
employed to investigate the overall efficacy of one treatment versus 
another. The body of BDD outcome literature stands at this preliminary 
state. Therefore, because change mechanisms of successful cognitive- 
behavioral treatment have not yet been identified, the current study 
utilized a single-participant design to examine processes that change over 
the course of both cognitive therapy and behavioral treatment. The 
following section discusses the characteristics of single-case designs, 
their advantages and disadvantages, and addresses issues regarding the 
scientific rigor of single-participant versus group designs. 
Single-participant designs are characterized by the repeated 
measurement of dependent variables over the course of an experimental 
manipulation. Although single-case designs may replicate these 
manipulations across additional participants, data analysis does not 
combine results across individuals to produce group averages. Instead, 
the goal is to examine the detailed development of behavior across time 
within a single individual, and to draw strong inferences about functional 
relationships through intra- and interparticipant replications (Morgan & 
Morgan, 2001). 
Although single-participant designs do not traditionally utilize the 
null hypothesis testing common to group designs, they are rooted in the 
scientific method and can produce very rigorous and meaningful results 
(Barlow, Hayes, & Nelson, 1984; Leitenberg, 1973; Morgan & Morgan, 
2001). For example, an important goal of scientific research is the 
demonstration of the experimental criterion. This criterion refers to the 
method of data evaluation used to determine whether an intervention has 
a reliable effect on behavior. Typically, the experimental criterion entails a 
comparison of behavior under varying conditions, such as intervention 
and nonintervention (Kazdin, 1984). Thus, in order for a series of single- 
subject designs to demonstrate scientific rigor, data must be evaluated in 
such a way as to meet the experimental criterion. 
Several such methods exist for single-case data that allow for the 
inference of causal relationships. Commonly, the visual inspection of 
detailed graphs, in which data points are plotted across separate phases, 
is used to evaluate reliable change (Baer, 1977; Michael, 1974). Such 
"eyeballing" of the data may appear to be subjective and lacking in the 
usual scientific standards that guide decision-making. However, for visual 
inspection to be properly conducted, specific data requirements must be 
met. In addition, the process of visual inspection and the conclusion of 
reliable behavior change are governed by specific criteria, such as 
changes in trend and latency of change (Kazdin, 1982; Parsonson & Bear, 
1978). Cause and effect relationships between intervention and behavior 
change may be inferred if such design requirements are met (Kazdin, 
1984). In fact, many proponents of single-participant designs argue that 
effects are only meaningful if clearly observable by visual inspection 
(Hopkins, Cole & Mason, 1998; Parsonson & Baer, 1986; Perone, 1999; 
Skinner, 1969). Thus, although some traditional Fisherian techniques are 
available for small N designs, they are considered to be ill-fitted and to 
undermine basic premises of single-case methodology (Lundervold & 
Bellwood, 2000; Perone 1999). 
As mentioned earlier, scientific rigor of the single-subject 
experimental design is increased by the fundamental characteristic of 
repeated measurement (Barlow, Hayes, & Nelson, 1984). Repeated 
assessments of the dependent variable are crucial in examining individual 
variability across baseline and treatment phases, and are necessary in 
identifying trends in the behavior of interest. In fact, the addition of 
repeated measurement to anecdotal case study is argued to be sufficient 
for upgrading to a quasi-experimental design (Browning & Stover, 1971). 
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In addition, repeated assessment allows for more ease in separating the 
treatment effect from measurement error and other extraneous variables 
(Barlow, Hayes, & Nelson, 1984). The detailed information provided 
through repeated measurement is an advantage of single-subject designs 
that is often lost in group studies, which typically assess the dependent 
variable only before and after treatment, and at follow-up. 
Another advantage to the single-subject design is the consideration 
of variability as valuable information in the examination of intraindividual 
changes. This approach to measurement allows for a more specific 
understanding of the factors that control an individual (Barlow, Blanchard, 
Hayes, & Epstein, 1977). Such a perspective is contrary to the view of 
group designs, in which variability is seen as error that must be explained. 
In most between-groups designs, measurements are conducted pre- and 
post-treatment. An average group response is calculated, and the 
amount that each individual differs from that average is considered 
intersubject variability, or error. A weak treatment effect may be the result 
of averaging the responses of clients who improve, deteriorate, or remain 
constant (Barlow & Hersen, 1987). By contrast, the single case design, 
because it incorporates variability into meaningful data, increases the 
understanding of individual behavior. Not only is this valuable and 
practical information lost in between-groups analyses, but the 
consideration of variability as error may mask actual differences. 
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The single subject experimental design also addresses the ethical 
issue of withholding treatment in treatment versus no-treatment group 
studies. When clients are suffering, there is an ethical dilemma in placing 
them in a waitlist control group. Many scientist-practitioners struggle with 
the decision to place a suffering client in a no-treatment group, yet a 
comparison group is necessary to demonstrate the effectiveness of a 
treatment manipulation (Barlow, et al., 1977; Barlow & Hersen, 1987). 
Single case methodology allows for the examination of interventions on an 
individual basis, in which individual behavior in a treatment phase is 
compared to baseline measurements of that same client. Thus, the need 
for a no-treatment group is reduced to a few weeks of baseline data- 
gathering. In fact, proponents of single-case designs argue that the 
comparison of a participant's behavior during the experimental phase to 
that of the baseline phase is more meaningful because in natural settings 
a clients' behavior is compared to pre-treatment behavior, not with the 
behavior of other clients. 
The most prominent difficulty with single-subject experimental 
designs is external validity, or generalizability of findings. Questions may 
arise as to whether information gained from the response of one client will 
be relevant to the treatment of other cases, or whether other clinicians 
would achieve similar results (Barlow et al., 1977). However, the use of a 
between-groups design does not ameliorate this difficulty. Problems also 
exist in generalizing from group results to an individual client. Hersen and 
Barlow (1 976) state that "the more adequate the sample, in that all 
relevant population characteristics are represented, the less relevance will 
this finding have for a specific individual" (p.55). The idea is that a more 
representative sample equals a more heterogeneous one, and that the 
average group response, therefore, will be less likely to generalize to that 
of an individual client. Barlow and colleagues (1 977) refer to this 
hypothetical average client as the "nonexistent average" (p.224). Thus, 
group designs are not necessarily the answer to the external validity 
issue, as the treatment effect for a particular client may be lost in the 
group average. 
The current study implements the single-case methodology of the 
multiple baseline technique. In this design, baseline responses are 
measured over time before any manipulation is conducted. These 
baselines differ in length across clients. Following the baseline, the 
intervention is conducted, and measures of the same dependent variable 
are taken. Thus, response changes that follow the treatment may be 
compared to baseline behaviors (Baer, Wolf, & Risley, 1968). The 
purpose of the multiple baseline is to correct for methodological 
weaknesses of the simple phase change. In a simple phase change 
where responses are measured during one baseline length and one 
phase of treatment, there is no protection against coincidental, extraneous 
events that influence behavior. In such cases, the researcher cannot be 
confident that changes in responding are due to the intervention. For 
example, an effect demonstrated by Participant 1 may be due to an 
external influence that occurs during treatment. The multiple baseline 
methodology replicates the phase change with other clients, allowing for 
improved internal validity. 
Another benefit of the multiple baseline design is the ability to 
control for assessment or time-related changes. The varying lengths of 
baselines act as controls for each other, in that such effects should be 
evident in each baseline. However, if treatment effects are demonstrated 
following the different baseline lengths, then one may be more confident 
of internal validity (Barlow et al., 1984). Thus, multiple baselines across 
clients improve confidence in treatment effects by arranging phase 
changes so that between series comparisons are possible. 
The current study also utilizes a crossover component in 
combination with the multiple baselines. In a crossover design, two series 
or conditions are synchronized such that two phase changes occur 
concurrently, but in the reverse order. In other words, clients in one 
condition will receive behavioral treatment followed by cognitive therapy, 
whereas individuals in the remaining condition will undergo cognitive 
therapy followed by behavioral treatment. An advantage to the crossover 
design is that control over external factors is increased through changing 
phases after the same number of sessions. Thus, consistent effects 
shown within both conditions are more convincing than simple, 
unsynchronized phase changes. One disadvantage to the crossover 
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design, however, is order effects. Because one treatment is followed by a 
second, it is uncertain whether effects demonstrated in the second phase 
are due to the second treatment or to delayed effects of the initial 
intervention. Despite this uncertainty, crossovers provide important 
information concerning the effectiveness of the first-order treatment and 
the combination of both treatments. 
Response covariation. The examination of change mechanisms is 
enhanced by identifying how different symptoms change in relation to 
each other over the course of treatment. Response covariation refers to a 
relationship between two responses such that a change in one response 
affects changes in the other (Kazdin, 1982). Such covarying of responses 
could result in therapeutic benefit, in that symptoms that are difficult to 
target may be treated indirectly through more easily targeted responses 
(Parrish & Roberts, 1993). For example, overvalued ideations found in 
OCD are thought to be resistant to challenging and to respond poorly to 
cognitive therapy (Kozak & Foa, 1994), yet behavioral treatment has been 
demonstrated to reduce the believability of obsessions (Lelliot et al., 
1988). Thus, one symptom may be addressed therapeutically through the 
targeting of an alternate symptom. For example, in the case of BDD, 
cognitive therapy may have little effect on reducing preoccupations with 
appearance and the frequency of negative self-statements. However, if 
negative self-statements covary with BDD-related behaviors (e.g., mirror- 
checking), then a reduction in such behaviors may cause a change in 
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those cognitive statements. Thus, through response covariation, BDD- 
related obsessions that are resistant to cognitive therapy may be targeted 
indirectly through the treatment of related behaviors. 
Thus far, no methodologically rigorous studies have examined the 
effects of behavior therapy on BDD-related cognitions. However, in one 
case study of relaxation training (Munjack, 1978), the client reported a 
subjective decrease in preoccupations. Also, in a series of case studies 
discussing the effects of ERP (Marks & Mishan, 1988), some clients did 
report a decrease in previously unshakable beliefs. Unfortunately, several 
of those participants began pharmacotherapy during the behavioral 
treatment and, therefore, improvement in symptoms cannot be attributed 
to behavior therapy. Geremia (1997) examined the effects of cognitive 
therapy on BDD symptoms, and demonstrated that the targeting of BDD- 
related cognitions resulted in a reduction of compulsive behaviors for two 
of the four participants. In addition, the OCD outcome literature 
demonstrates that successful behavior therapy reduces frequency and 
believability of obsessions (Foa & Goldstein, 1978; Ito, et al., 1995, Lelliot 
et al., 1988). 
Thus, the identification of covarying clusters of symptoms may aid 
in more effective treatment by revealing alternative and indirect treatment 
targets. First, however, there is a need to identify these components or 
processes that must be changed. In other words, before we investigate 
whether a change in negative self-statements will affect change in 
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compulsive checking behaviors, we need to determine whether frequency 
of checking must change before treatment is successful. The current 
study examines daily changes in cognitions and behaviors throughout the 
course of therapy in order to identify whether changes in these processes 
are required for successful treatment. In addition, the covariation of 
cognitions and behaviors are examined over the course of both cognitive 
and behavioral treatment in order to investigate whether targeting of one 
process affects changes in the other. The covariation of BDD-related 
behaviors and cognitions over the course of behavior and cognitive 
therapies will be examined in the current study. 
Current Study 
The current study investigated particular aspects of behavioral and 
cognitive theories of BDD through examining daily changes in behaviors 
and cognitions over the course of behavior and cognitive therapies. 
In keeping with the fear maintenance stage of Mowrer's two-factor 
theory, behavioral theory for BDD states that BDD-related behaviors are 
maintained through negative reinforcement. As discussed previously, 
rituals (e.g., mirror-checking) and avoidance behaviors (e.g., 
camouflaging) are hypothesized to decrease discomfort elicited by 
appearance-related thoughts and situations, and are maintained because 
of their ability to decrease the aversive response. In addition, the 
performance of these behaviors artificially decreases discomfort and 
prevents the natural habituation process. If this theory were accurate, then 
interrupting the reinforcing properties of rituals and avoidance through 
ERP would result in an overall decrease in BDD-related behaviors. The 
BDD outcome literature has demonstrated that a combination of ERP and 
CT reduces BDD symptoms. However, a detailed investigation on the 
effects of ERP alone on reducing overall BDD behaviors has not been 
conducted. 
In the OCD outcome literature, ERP has been shown to decrease 
OCD-related behaviors, cognitions, and associated distress. Therefore, if 
these change processes can be extrapolated to BDD, then a successful 
course of ERP would be expected to reduce unhelpful cognitions and 
negative affect, as well as behavior. The current study conducts a 
detailed investigation into processes that change over the course of ERP, 
and examines procedures consistent with the theory that BDD-related 
behaviors and cognitions are maintained through negative reinforcement 
patterns. 
Although the implementation of ERP often improves OCD 
symptoms, it would be erroneous to assume that the only mechanism for 
improvement could be an interruption in negative reinforcement patterns 
and habituation of a learned response. Other theories have been 
proposed as possible explanations for the therapeutic effect of ERP. For 
example, emotional processing theory (Rachman, 1980) and its 
adaptation to anxiety disorders (Foa & Kozak, 1991 ) proposes that 
exposure therapy achieves its gains through the modification of a fear 
structure. Emotional processing involves the integration of information 
into an existing fear structure that is incompatible with the pathological 
elements of that structure. Exposure therapy is proposed to provide that 
incompatible information, allowing for a reduction in fear by changing the 
meaning of the feared event by demonstrating a reduction in the 
probability of harm, while also allowing habituation of the physiological 
response (Foa & Kozak, 1991 ). 
Similarly, self-efficacy theory (Bandura 1986; 1988) states that 
fearful behaviors arise from low self-efficacy (i.e., lack of belief in one's 
own coping abilities in the face of fearful stimuli). The change mechanism 
of exposure therapy is believed to be an increased sense of mastery 
following the successful completion of exposure trials. Yet another 
possible explanation for the success of behavior therapy could be the 
altering of cognitions following a successful ERP trial and subsequent 
increase in activity. Thus, several possible explanations exist for the 
therapeutic success of ERP, preventing a definitive test of behavioral 
theory in the current study. 
Alternately, cognitive theory of BDD states that BDD symptoms are 
maintained through a combination of distorted thinking patterns and 
ongoing negative self-statements. In addition, Beck's general cognitive 
theory (from which BDD cognitive theory was derived) proposes that the 
most effective point of intervention to change cognitions, behaviors, and 
affect lies with altering the cognitions. Therefore, cognitive theory 
proposes that overall therapeutic change results from reductions in 
cognitive distortions and negative self-statements. The current study 
investigates the theory that BDD symptoms are maintained through 
cognitive distortions and negative self-statements by investigating whether 
these statements decrease over the course of cognitive therapy. 
However, as with the testing of behavioral theory, challenges exist 
with empirically testing the validity of BDD cognitive theory. That is, 
results demonstrating effective cognitive therapy, while consistent with the 
theory, would not prove that proposed change mechanisms were the 
actual maintaining factors. In other words, cognitive therapy could result 
in amelioration of BDD symptoms through entirely different processes 
other than those assumed by cognitive theory. For example, McFall and 
Wollersheim (1 979) proposed that individuals with OCD match the 
perceived threat of an event with their ability to cope, and that the 
challenging of expected catastrophic outcomes allows for a more 
appropriate match between threat and coping ability. Alternately, 
discussions regarding the effectiveness of cognitive therapy for OCD have 
noted that cognitive therapy often requires behavioral experiments or 
naturally leads to an increase of behavioral activity (Abromowitz, 1997). 
Thus, the fact that cognitive therapy may be effective through 
mechanisms other than the alteration of maladaptive schemas makes the 
testing of that theory difficult. 
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Also of importance is determining the particular aspects of the CBT 
package that result in symptom relief. In very practical terms, the 
identification of crucial components and the elimination of extraneous 
elements are time- and cost-effective. In addition, the inclusion of 
unnecessary elements could serve to dilute the overall effectiveness of 
the treatment by guiding efforts away from the most crucial aspects of 
intervention. For example, if the proposed investigation determined that 
cognitive challenging did not contribute in a clinically significantly manner 
to the reduction of BDD symptoms, then therapeutic efforts could center 
on behavioral exercises. Thus, the identification of necessary treatment 
components could make for a more powerful and effective intervention. 
The current study examined clinically significant change following both 
behavior and cognitive therapies. 
Using a multiple baseline series, six clients were randomly 
assigned to one of two conditions. Clients in Condition One underwent 
baseline assessment, followed by eight bi-weekly sessions of CT, another 
period of baseline assessment, and eight bi-weekly sessions of BT. 
Clients in Condition Two underwent the same sequence of baseline and 
treatment, but received BT as the initial treatment followed by CT (Figure 
1 ). 
Within each condition, clients were assigned to one of three 
multiple baselines. Baseline One involved one week of baseline 
measurement followed by the first treatment, three weeks of baseline, and 
the second treatment. Baseline Two entailed two weeks of baseline 
measurement, treatment, two weeks of baseline, and treatment. Finally, 
clients in Baseline Three underwent baseline measurement for three 
weeks, followed by treatment, one week of baseline, and treatment. 
Throughout the study, three measurements were conducted on a daily 
basis: an idiosyncratic behavior (e.g., frequencylduration of mirror- 
checking) was monitored daily to assess behavioral change; a frequency 
count of negative self-statements was recorded daily to assess cognitive 
change; and a rating of global distress was recorded daily to assess 
affective change. Thus, the daily measures of cognition, behavior, and 
affect provided a very detailed picture of changing processes throughout 
the two treatments. In addition to these daily measurements, a semi- 
structured clinical interview and a battery of BDD-related measures were 
administered at all phase change points throughout the study, and third- 
party ratings were collected weekly. 
Hvpotheses Related to Behavior Therapy 
Hypothesis 1 : Behavior therapy will result in decreases in daily 
frequencies of appearance-related compulsions. 
Hypothesis 2: Behavior therapy will result in deceases in daily 
frequencies of appearance-related negative self-statements. 
Hvpothesis 3: During behavior therapy, the reduction in daily 
negative self-statements will not be as great as the reduction in daily 
compulsive behaviors. 
Hypothesis 4: Behavior therapy will result in decreases in daily 
distress levels. 
Hypotheses Related to Coqnitive Therapy 
Hvpothesis 5: Cognitive therapy will result in decreases in daily 
frequencies of appearance-related negative self-statements. 
Hypothesis 6: Cognitive therapy will result in decreases in daily 
frequencies of appearance-related compulsions. 
Hypothesis 7: During cognitive therapy, the reduction in daily 
compulsive behaviors will not be as great as the reduction in daily 
negative self-statements. 
Hvpothesis 8: Cognitive therapy will result in decreases in daily 
distress levels. 
Hvpothesis Related to Combined Coqnitive and Behavioral Therapies - 
Hypothesis 9 
Both behavior therapy and cognitive therapy are predicted to be 
necessary for clinically significant change. Neither behavior therapy nor 
cognitive therapy alone will be sufficient in decreasing BDD-related 
symptoms to a clinically significant degree. 
Chapter 2 
METHOD 
Participants 
Participants were two males and three females, ranging in age 
from 21 to 44, who met diagnostic criteria for BDD. Education level 
ranged from high school completion to a Masters degree. A sixth male 
participant began the study but discontinued. Participants were recruited 
from both Maine and Manitoba communities through local advertisements 
and through referrals from other mental health professionals. The 
diagnosis of BDD was determined using the Body Dysmorphic Disorder 
Examination (BDDE, Appendix A; Rosen & Reiter, 1996). The BDDE is a 
semi-structured clinical interview designed for diagnostic purposes, and 
for assessing the presence and severity of BDD symptoms. Four of the 
six participants were taking medication for psychological disorders at the 
time of this study, and were permitted to participate provided they were 
stabilized on the medication for at least four weeks. Exclusion criteria 
included the diagnosis of anorexia nervosa or a psychotic disorder, active 
alcohol or substance abuse, and concurrent psychotherapy. 
Therapists 
Two clinical psychology interns and one clinical psychology 
doctoral student conducted the individual therapy sessions, and were 
supervised by a licensed clinical psychologist. All three therapists had a 
background in cognitive-behavior therapy, and were further trained in the 
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cognitive-behavioral models of BDD and treatment techniques specific to 
the disorder. In addition, training was conducted regarding the design of 
the study, and therapists followed a detailed treatment manual. 
Adherence to the treatment protocol was monitored through individual 
supervision sessions that followed each therapy session. 
Measures 
Total Compulsive Behavior Score (TCBS). On a daily basis, clients 
were asked to record compulsive behaviors. The daily score represented 
the number of compulsive behaviors performed or total amount of time 
spent ritualizing in a given hour. The particular behavior and hour in 
which measurement was taken were chosen on an idiographic basis and 
remained consistent throughout the entire study. For example, if the most 
prominent ritual was mirror-checking, then the participant recorded the 
number and/or the duration of checks during the same hour each day. 
The TCBS was calculated by summing the minutes spent ritualizing or the 
number of behaviors conducted in that hour. Appendix B presents the 
behavior measured for each participant. A reduction in the TCBS was 
used as an indication of treatment success. 
Total Neqative Self-statements Score (TNSS). On a daily basis, 
clients were asked to record the number of negative appearance-related 
self-statements during a chosen hour. Clients were provided with a 
mechanical counter, and asked to record every occurrence of a negative 
self-statement during this hour. As with the TCBS, the measurement hour 
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was chosen on an idiographic basis, and reflected the hour in which these 
thoughts were most frequent. The TNSS was calculated by summing the 
number of negative thoughts in that hour, and a reduction in this score 
was considered indicative of treatment success. 
Global Distress Rating (GDR). For the third daily measure, clients 
were asked to record their average level of distress throughout the entire 
day. Ratings were to range from 0 to 100, and a reduction in this score 
was considered indicative of treatment success. 
Third Partv Measure. On a weekly basis, participants were asked to obtain 
additional data from a person who lived with the client and who was knowledgeable 
about the appearance concerns. Once a week, the participant was provided with a 
form (Appendix C) requesting the third party to ( i )  rate on a 10-point scale the average 
amount of effort the participant exerted that week related to appearance concerns, and 
(ii) indicate the number of times the participant asked for reassurance that day. 
Body Dvsmorphic Disorder Examination (BDDE). The BDDE 
(Appendix A; Rosen & Reiter, 1996) is a 32-item semi-structured clinical 
interview designed as a diagnostic instrument, as well as a tool for 
assessing typical BDD symptoms that may be targeted for treatment. A 
total score of 60 or greater (out of a possible score of 166) is indicative of 
the presence of BDD. The interview taps into self-consciousness and 
preoccupation with physical appearance, overvalued ideations about the 
importance of appearance in self-evaluation, avoidance of social 
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situations or exposure of the appearance defects, and body camouflaging 
and body checking behaviors. 
The BDDE has demonstrated satisfactory reliability and validity 
(O'Grady, Thorpe, & Kubik, 1998; Rosen & Reiter, 1996), good test-retest 
reliability (1 = .96 for two-week period), inter-rater reliability (1 = -94 to .98), 
and internal consistency (1 = .93). The BDDE correlated significantly with 
other measures of BDD, and successfully discriminated clients referred for 
body image problems from non-clinical individuals with body image 
complaints and normal controls (Rosen & Ramirez, 1998; Rosen & Reiter, 
1 996). 
The Yale-Brown Obsessive Compulsive Scale for Body 
Dysmorphic Disorder (YBOCS-BDD). The YBOCS-BDD (Appendix D; 
Phillips, Hollander, Rasmussen, Aronowitz, DeCaria, & Goodman, 1997) 
was adapted from the YBOCS (Goodman, Price, Rasmussen, Mazure, 
Fleischmann, et al., 1989), a widely used measure of obsessive 
compulsive disorder. The self-report version of the YBOCS-BDD consists 
of 10 items that measure time spent engaging in BDD-related obsessions 
and compulsions, as well as the intensity of distress, amount of 
interference in daily functioning, and the level of subjective control over 
obsessions and compulsions. Each item is rated on a 0- to 4-point scale, 
with separate scores calculated for the obsession and compulsions 
subscales. 
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The clinical interview version of the YBOCS-BDD showed good 
internal consistency (1 = .80) and test-retest reliability (1 = .88 for one week 
interval). Total scores on the YBOCS-BDD were significantly correlated 
with scores on the Clinical Global Impression Scale but not the Brief 
Psychiatric Rating scale, indicating adequate convergent and discriminant 
validity. Sensitivity to symptom improvement was demonstrated with 26 
clients following a 16-week pharmacological trial (Phillips et al., 1997). 
The Appearance Schemas Inventory (ASI). The AS1 (Appendix E; 
Cash & Labarge, 1996) is a 14-item, self-report measure designed to 
assess beliefs and assumptions concerning the importance, meaning, and 
effects of appearance on one's life. Items are rated on a five-point scale 
of "strongly disagree" to "strongly agree." The AS1 demonstrates 
acceptable internal consistency (coefficient alpha = .84; Cash & Labarge, 
1996). Good construct validity was shown through moderate to high 
correlations with other body-image measures (1 = .48 to .64) and unique, 
incremental variance over and above those measures (R-squared = .57; 
p<.001). In addition, the AS1 differentiated between clinical body-image 
groups and non-clinical groups. An investigation of the factor structure 
revealed three factors that were termed body-image vulnerability, self- 
investment, and appearance stereotyping. 
The Social Avoidance and Distress Scale (SADS). The SADS 
(Appendix F; Watson & Friend, 1969) is a 28-item, truelfalse measure 
designed to assess distress associated with social and interpersonal 
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situations, as well as the behavioral avoidance of those situations. The 
maximum possible score is 28, with higher scores indicative of higher 
levels of anxiety and poor adjustment to social environment. 
The SADS demonstrates acceptable internal consistency (.77 to 
.94; Robinson, Shaver, & Wrightsman, 1991) and test-retest reliability (.68 
to .94 over four week period; Watson & Friend, 1969). A correlation of .45 
between the social and evaluative scales of the S-R Inventory of 
Anxiousness (Endler & Hunt, 1966) demonstrated adequate convergent 
validity. Discriminant validity was demonstrated with the Affiliation Scale 
of Jackson's (1966, as cited in Geremia, 1997) Personality Research 
Form (r = -.76). 
The Overvalued Ideas Scale (OVIS). The OVlS (Appendix G; 
Neziroglu. Yaryura-Tobias, McKay, Stevens, & Todaro, 1998, as reported 
in Geremia 1997) is a nine-item, self-report inventory that assesses the 
degree to which individuals believe that particular fears are realistic and 
compulsions are necessary. Each item is rated on a scale of one to ten, 
with higher ratings indicating greater overvalued ideation. Good internal 
consistency (1 = .96) was demonstrated using a group of 48 individuals 
diagnosed with OCD. Convergent validity was indicated with a significant 
correlation (1: = .69) between the OVlS total score and a YBOCS item that 
assesses insight into obsessive-compulsive symptoms. The correlation of 
a depression scale with the OVlS (1 = -.12) demonstrated discriminant 
validity. 
66 
The Beck Depression Inventory- II (BDI-11). The BDI-II (Appendix 
H; Beck, Steer, & Brown, 1996) is a 21 -item, self-report questionnaire that 
taps into the cognitive, affective, behavioral, and biological features of 
depression. Each item is rated on a 0- to 3-point scale of severity, with 
higher ratings indicating greater severity of symptoms. Total scores on 
the BDI-II may describe an individual as severely, moderately, or mildly 
depressed. Low scores indicate the absence of depression. 
The BDI-II is psychometrically sound (Beck et al., 1996). The 
instrument demonstrates good internal consistency (alpha = .92) and test- 
retest reliability (1 = .93). Significant correlations with scales that measure 
depressive symptoms (Beck Hopelessness Scale, r = .68; Hamilton 
Psychiatric Rating Scale for Depression, 1 = -71) and significant, but 
lower, correlations with anxiety measures (Hamilton Rating Scale for 
Anxiety, I = .47) indicate convergent and discriminant validity. A principal 
components analysis identified two factors, termed Somatic-Affective 
(standardized-regression coefficients 2 .35) and Cognitive (.33). 
Desiqn 
Six clients were randomly assigned to one of two conditions 
(Appendix I). Clients in Condition One received eight sessions of CT, 
followed by the same number of BT sessions, whereas participants in 
Condition Two underwent the same treatments but in the reverse order. 
Within each condition, participants were assigned to one of three initial 
baseline periods (one, two, or three weeks). A second baseline 
assessment period was implemented at the midpoint of treatment (i.e., 
following treatment one and prior to treatment two). These midpoint 
baselines also differed in length (three, two, or one weeks), depending on 
the number of initial baseline weeks, to amount to four weeks of total 
baseline assessment time. Baseline One involved three weeks of 
baseline measurement followed by the first treatment, one week of 
assessment, and the second treatment. Baseline Two entailed two weeks 
of baseline, treatment, two weeks of measurement, and treatment. 
Finally, clients in Baseline Three underwent baseline assessment for 
three weeks, followed by treatment, one week of baseline, and treatment. 
During baseline assessment, two measurements were conducted. 
An idiosyncratic behavior (e.g., duration of mirror-checking) was 
monitored daily to assess behavioral change, whereas cognitive change 
was monitored with a daily frequency count of negative, appearance- 
related self-statements. In addition, a battery of outcome measures was 
administered repeatedly throughout the study (Appendix J). 
Procedure 
Assessment. Individuals responding to study advertisements were 
screened on the telephone for appropriateness in the study. 
Respondents who were diagnosed with anorexia nervosa or a psychotic 
disorder or those who had an active alcohol or substance abuse problem 
were considered inappropriate for the study, and were referred elsewhere 
for services. Individuals who described preoccupations with appearance 
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defects that interfered with daily functioning were invited to participate in a 
more comprehensive, face-to-face interview. For those individuals who 
were taking medications for psychological disorders, the interview was 
scheduled once a stable dosage for four weeks had been maintained. 
During the interview, the BDDE was administered in order to 
determine whether participants met criteria for BDD. Once a diagnosis of 
BDD had been determined, clients were invited to take part in the 
research study. Participants were informed about the procedures of the 
study and were given a consent form to read and sign. Those individuals 
who did not meet these criteria offered referrals to other mental health 
practitioners. 
In keeping with single-case methodology, assessment continued 
frequently throughout treatment. As discussed above, each client 
participated in a pre-treatment baseline assessment. Daily counts of both 
rituals and negative cognitions were recorded throughout the baseline 
period, as well as during both behavioral and cognitive phases of 
treatment. In addition to the daily recordings of specific symptoms, a 
battery of measures was administered at each phase change (Appendix 
J). The battery included the YSOCS-SDD, SDI-ll, OVI, Appearance 
Schemas Inventory, and SADS. The BDDE interview also was conducted 
at phase changes in order to assess whether individuals still met criteria 
for the disorder. 
Behavior therapy. Behavior therapy consisted of eight one-hour 
sessions twice per week. Session 1 was psychoeducational in nature and 
explained BDD in terms of the behavioral model. A behavioral analysis of 
antecedents, consequences, and avoidance behaviors was conducted 
and discussed with the client. Then, a rationale for ERP was discussed, 
and a detailed hierarchy of anxiety-provoking ERP exercises was 
developed in a collaborative manner. Hierarchy items included both in- 
session and homework scenarios and focused on the exposure of the 
body part in public situations and the prevention of anxiety-reducing 
rituals. Examples of ERP hierarchy items included creating a fake pimple 
on face while avoiding mirror-checking or covering-up, wearing a form- 
fitting shirt to a busy waiting area while refraining from covering-up or 
fleeing the area, and allowing the therapist to stare at lips while avoiding 
talking or placing hand in front of mouth. 
Throughout Sessions 2 to 8, ERP exercises were conducted in a 
graduated manner, both in session and as homework. Once hierarchy 
items were selected, clients were instructed to remain in the situation until 
discomfort decreased, without using the traditional distress-relieving 
compulsions. Distress levels were measured by the Subjective Units of 
Distress Scale (SUDS; Appendix K). The SUDS is a 100-point Likert 
rating scale in which zero represents 'no anxiety' and 100 represents 
'worst possible anxiety.' Clients were asked to record SUDS ratings at 
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approximately two-minute intervals throughout ERP exercises. ERP trials 
were discontinued once SUDS ratings decreased to 20 to 30. 
The initial ERP trial was conducted in the presence of the therapist 
in order to ensure proper execution of the exercise. Because of the 
distressing nature of ERP, clients tend to terminate the exercise 
prematurely, or to engage in other anxiety-reducing techniques (e-g., self- 
talk). Therefore, clients were reminded continually of the rationale for 
ERP and the beneficial nature of experiencing the anxiety as fully as 
possible. Progression to the next hierarchy level followed participants' 
sense of mastery on lower-rated items. 
Cognitive therapy. Cognitive therapy was provided in eight one- 
hour sessions twice a week. Clients receiving CT underwent cognitive 
restructuring procedures based on the principles of Beck's model of 
cognitive therapy (Beck, 1995). Session 1 was predominantly 
psychoeducational in nature and described BDD in terms of the cognitive 
model. Participants were provided with a list of cognitive distortions 
common among those with BDD (Geremia, 1997; Appendix L), and 
idiosyncratic cognitive errors were postulated. Details about the perceived 
defect and the resulting distress were discussed, as well as the impact on 
social and occupational functioning. Dysfunctional attitudes and unhelpful 
automatic thoughts were explored in a preliminary manner, along with 
discussion surrounding developmental antecedents of body image 
problems, sociocultural and familial factors, and immediate sources of 
body image distress. 
In Sessions 2 through 8, participants kept daily thought diaries 
(Appendix M) in which they recorded automatic thoughts, fluctuations in 
mood, situational details, and resultant changes in behavior. For 
example, a client may write, "I was having coffee with my friend and she 
was staring at my hair. I bet she thought my hair was too fuzzy and that 
no one else would want to be my friend. I am so ugly and stupid. I felt 
embarrassed and told her I had to leave." Then, these recordings were 
discussed and evaluated in session. The validity of disturbing automatic 
thoughts was challenged, in a collaborative manner, by examining 
evidence for and against the thought, determining alternative explanations 
to the thought, and evaluating the importance of the thought on feelings. 
The goal of such validity-testing was to challenge cognitive distortions 
underlying the distressing automatic thoughts. Particular attention was 
paid to the more damaging beliefs concerning the implications of 
appearance for self-worth. 
With practice, clients were encouraged to recognize maladaptive 
automatic thoughts and cognitive errors, and to begin challenging their 
validity throughout daily activities. As such skills were developed, clients 
practiced generating more accurate thoughts to replace the negative self- 
statements. Participants were encouraged to interrupt negative self- 
statements as they occur, replace them with the more neutral thoughts, 
and evaluate the effect on emotion. For example, the client discussed 
above may challenge her beliefs that she was an ugly and unwanted 
friend by thinking "if I really were that ugly then my companion wouldn't be 
able to tolerate sitting across from me", and "if no one wanted to be my 
friend then I wouldn't receive the social invitations that I do." This 
challenging could eventually lead to the generation of more accurate 
replacement thoughts, such as "my hair is fluffy and curly [versus fuzzy 
and ugly]", and "friends enjoy my company." 
Once participants demonstrated an ability to challenge cognitive 
distortions, CT progressed to the identification of more underlying core 
beliefs. Thus, automatic thoughts were pursued in order to identify the 
connection between physical appearance and inherent character traits 
(e.g., lovability, worthiness). Once identified, the validity of core beliefs 
(e.g., "I am worthless"; "I am unlovable") was challenged with the goal of 
altering the underlying schema. 
Follow-up Assessment 
Two months following the completion of treatment, a follow-up 
assessment was conducted, including re-administration of the BDDE 
diagnostic interview and battery of self-report measures. 
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RESULTS 
The following daily data were visually analyzed according to published 
guidelines (Parsonson & Baer, 1978; Appendix N.), and questionnaire data were 
analyzed in accordance with guidelines for computing clinical significance 
(Jacobson & Truax, 1991; Appendix 0). With regard to BDDE scores, clinical 
significance was demonstrated once the individual no longer met criteria for the 
disorder. Due to order effects, hypotheses regarding the effects of BT or CT 
were discussed in terms of participants who received that treatment as the initial 
intervention. Case descriptions of the five participants and their qualitative 
responses to treatment are presented in Appendix P. 
Hvpotheses Related to Behavior Therapy 
Clients 1, 2, and 3, received BT as the first treatment after varying 
baseline periods (Client 1, 7 days; Client 2, 14 days; Client 3, 21 days). These 
clients were used to test hypotheses regarding BT alone. 
Hvpothesis 1. It was predicted that BT would result in behavior change as 
demonstrated by a reduction in daily TCBS. Clients 2 and 3 demonstrated the 
predicted drop in TCBS coincident with the introduction of BT. Client 1 did not 
show the effect. (See Figures 1,2, &3; Tables 1,2, & 3). 
During baseline, Client 2 demonstrated a wide range of TCBS (90-20; Figure 2), 
with mean weekly baseline TCBS of 66 and 61 (Table 2). These behaviors 
decreased over the course of BT, such that TCBS ranged from 25 to 2, with 
TCBS consistently below 10 during the final week of BT. Mean weekly 
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Fiqure 1. Daily Total Compulsive Behavior Scores (TCBS) across all phases for 
Client 1. 
Fiqure 2. Daily Total Compulsive Behavior Scores (TCBS) across all phases for 
Client 2. 
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Table 1. 
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TCBS, during BT, ranged from 25 to 12. In addition, these low scores 
continued throughout the second baseline and subsequent course of CT. 
During baseline, Client 3 demonstrated a wide frequency range in TCBS 
(30-0; Figure 3), with a slight downward trend (weekly means = 16 & 9; Table 3). 
However, TCBS decreased in range over the course of BT (1 5-O), and remained 
consistently at zero during the second baseline. TCBS also remained at a stable 
low rate over the subsequent course of CT. 
In addition, BT was predicted to result in decreases in third party ratings of 
reassurance-seeking and behavioral effort. Unfortunately, third party ratings 
were not available for any of these participants. Due their efforts to maintain 
secrecy, none of these individuals had disclosed their concerns to the significant 
others with whom they lived. 
Hypothesis 2. It was predicted that that BT also would result in 
cognitive change, as demonstrated by a decrease in daily TNSS. Client 
3 demonstrated a reduction in TNSS over the course of BT. Clients 1 and 
2 did not demonstrate the predicted effect. (See Figures 4, 5, & 6) 
During baseline, Client 3 recorded a wide frequency range of TNSS (1 1-0; 
Figure 6), with a slight downward trend (weekly means = 5, 4, & 2; Table 3). 
TNSS decreased in range over the course of BT (4-0) for this client and 
remained consistently at zero during the second baseline. TNSS remained at a 
stable low rate over the subsequent course of CT. 
BSL 2 
Fiqure 4. Daily Total Negative Self-Statement Scores (TNSS) across all phases 
for Client 1. 
Figure 5. Daily Total Negative Self-Statement Scores (TNSS) across all phases 
for Client 2. 
Figure 6. Daily Total Negative Self-statement Scores (TNSS) across all phases 
for Client 3. 
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Hvpothesis 3. It was predicted that the reduction in daily negative self- 
statements (TNSS) would not be as great as the reduction in compulsive 
behaviors (TCBS). Client 2 and Client 3 did demonstrate greater decreases in 
TCBS than TNSS over the course of BT. Client 1 demonstrated no change in 
either TCBS or TNSS during the course of BT (See Figures 7, 8,  & 9). 
Hypothesis 4. It was predicted that BT would result in reductions in 
daily distress levels (GDR). Client 3 demonstrated a notable decrease in 
GDR over the course of BT (See Figures 10,11,& 12). 
During baseline, Client 3 endorsed a wide range of GDR (90-20; 
Figure 12), with weekly means of 60, 37, & 41 (Table 3). GDR decreased 
over the course of BT (range = 50 - 20), and decreased further during the 
second baseline (range = 30-15). Client 1 demonstrated a moderate 
decrease in GDR (Figure lo), whereas Client 2 did not demonstrate any 
notable change in GDR over the course of BT (Figure 11). 
Hypotheses Related to Coqnitive Therapy 
Clients 4 and 5 received CT as the first treatment after varying baselines 
(Client 4, 7 days; Client 5, 14 days). These clients were used to test hypotheses 
regarding CT alone. 
Hypothesis 5. It was predicted that CT would result in cognitive change, 
as demonstrated by a reduction in daily TNSS. Client 5 demonstrated the 
predicted decrease in TNSS over the course of CT (See Figures 13 & 14; Tables 
4 & 5). 
Figure 7. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative 
Self-Statement Scores (TNSS) across all phases for Client 1. 
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Fiqure 8. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative 
Self-Statement Scores (TNSS) across all phases for Client 2. 
Fiqure 9. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative 
Self-statement Scores (TNSS) across all phases for Client 3. 
Figure 10. Daily Global Distress Ratings (GDR) across all phases for Client 1. 
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Figure 12. Daily Global Distress Ratings (GDR) across all phases for Client 3. 
Fiqure 13. Daily Total Negative Self-Statement Scores (TNSS) across all 
phases for Client 4. 
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Fisure 14. Daily Total Negative Self-Statement Scores (TNSS) across all 
phases for Client 5. 
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During baseline, Client 5 demonstrated a moderate frequency range of 
TNSS (6-0; Figure 14), with mean weekly baseline TNSS of 3 and 2 (Table 5). 
As predicted, TNSS decreased in range over the course of CT (2-O), with mean 
weekly TNSS ranging from 1 to 0. In addition, these low scores continued 
throughout the second baseline. Client 4 did not demonstrate a decrease in 
TNSS over the course of CT. 
Hypothesis 6. It was predicted that CT also would result in 
behavior change as demonstrated by a reduction in daily TCBS and a 
reduction in third party measures of behavioral effort. Neither Client 4 nor 
Client 5 demonstrated decreases in TCBS over the course of CT (Figures 
15 & 16; Tables 4 & 5). However, compared to baseline, Client 5 did 
demonstrate a decrease in third-party ratings of reassurance-seeking 
(Figure 17) and behavioral effort (Figure 18) over the course of CT. The 
recording of third party ratings was considered inappropriate for Client 4 
due to the current abuse by her significant other. 
Hypothesis 7. It was predicted that the reduction in daily 
compulsive behaviors (TCBS) would not be as great as the decrease in 
negative self-statements (TNSS). Client 5 demonstrated a greater 
decrease in TNSS than TCBS over the course of CT (Figure 20). Client 4 
demonstrated no change in either TNSS or TCBS during the course of CT 
(Figure 19). 
Figure 15. Daily Total Compulsive Behavior Scores (TCBS) across all phases 
for Client 4. 
Figure 16. Daily Total Compulsive Behavior Scores (TCBS) across all phases 
for Client 5. 
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Fiqure 1 7. Number of reassurance-seeking behaviors recorded by a third party 
over a one day per week period for Client 5. 
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Fiqure 18. Weekly average ratings of appearance-related behavioral effort 
recorded by a third party for Client 5. 
Fiqure 19. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative 
Self-Statement Scores (TNSS) across all phases for Client 4. 
CT BSL 2 
Fiqure 20. Daily Total Compulsive Behavior Scores (TCBS) and Total Negative 
Self-Statement Scores (TNSS) across all phases for Client 5. 
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Hypothesis 8. It was predicted that CT would result in reductions in 
daily distress levels (GDR). Client 5 demonstrated a decrease in GDR 
during the end of the CT period (See Figures 21 & 22). During the 
baseline, Client 5 recorded a wide range of distress ratings (76-20; Figure 
22), with weekly means of 54 and 44 (Table 5). As predicted, overall 
distress decreased such that, during the final week of CT, GDR ranged 
from 36 to 15 with a mean of 24. 
Client 4 did not demonstrate a decrease in distress ratings over the 
course of CT (Figure 21, Table 4). 
Hypothesis Related to Combined Coqnitive and Behavioral Therapies - 
Hypothesis 9 
It was predicted that both BT and CT would be necessary to result 
in clinically significant reductions on self-report measures and on the 
structured interview. Details regarding the computation of clinical 
significance are presented in Appendix N. 
As predicted, Client 5 demonstrated clinically significant reductions 
on the YBOCS-BDD and BDI-II following the completion of both CT and 
BT (Table 6). In addition, Client 5 no longer met criteria for BDD following 
the completion of both treatments, as determined by BDDE scores. 
Clinically significant decreases were not demonstrated for the ASI, OVIS, 
or SADS. 
Figure 21. Daily Global Distress Ratings (GDR) across all phases for Client 4. 
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Fisure 22. Daily Global Distress Ratings (GDR) across all phases for Client 5. 
Table 6. 
Questionnaire and Structured Interview Data for Client 5 
+ clinically significant improvement 
++ no longer meets criteria for BDD 
POST- 
BT 
40++ 
9+ 
2.14 
2.88 
10 
6+ 
BDDE 
YBOCS- 
BDD 
AS I 
OVlS 
SADS 
BDI-II 
FOLLOW- 
UP 
31 ++ 
8+ 
2.29 
6.38 
8 
10 
POST- 
CT 
65 
13 
2.36 
5.75 
24 
17 
PRE- 
BT 
68 
14 
2.57 
5.88 
24 
17 
P RE- 
BSL 
104 
22 
2.85 
8.38 
24 
23 
PRE- 
CT 
105 
20 
2.50 
8.5 
24 
27 
Also as predicted, Client 2 demonstrated clinically significant 
improvement following the completion of both treatments, as determined 
by BDDE and BDI-II scores (Table 7). However, Client 2 also showed 
clinically significant reductions in YBOCS-BDD scores following the 
completion of BT only. This improvement in YBOCS-BDD scores was 
maintained throughout CT and at follow-up. 
Client 3 met criteria for clinically significant improvement following 
completion of BT only, as determined by scores on the BDDE and YBOCS-BDD 
(Table 8). These improvements in BDDE scores were maintained throughout CT 
but lost at follow-up. The reductions in YBOCS-BDD scores were lost 
immediately following the completion of BT. 
Client 1 and Client 4 did not demonstrate clinically significant reductions 
on any of the self-report measures (Tables 9 & 10). 
Table 7. 
Questionnaire and Structured Interview Data for Client 2 
PRE- 
BSL 
BDDE 
PRE- 
BT 
YBOCS- 
BDD 
AS I 
POST- 
BT 
62 
OVlS 
22 
2.29 
SADS 
PRE- I POST- I FOLLOW- 
65 
4.13 
+ clinically significant improvement 
++ no longer meets criteria for BDD 
65 
23 
2.29 
2 1 
BDI-II 
Table 8. 
1 O+ 
1.86 
4.13 
23 24 
Questionnaire and Structured Interview Data for Client 3 
4.38 
21 
18 
18 
+ clinically significant improvement 
++ no longer meets criteria for clinically significant change 
BDDE 
YBOCS- 
BDD 
AS I 
OVlS 
SADS 
BDI-II 
PRE- 
CT 
41 ++ 
13+ 
2.86 
2.75 
16 
20 
PRE- 
BSL 
74 
26 
3.36 
4.63 
25 
26 
POST- 
CT 
35++ 
17 
3.21 
3.50 
18 
20 
FOLLOW- 
UP 
50 
17 
2.93 
3.75 
14 
13 
PRE- 
BT 
89 
28 
3.36 
5.88 
21 
3 1 
POST- 
BT 
57 
9+ 
3.00 
3.00 
17 
18 
Table 9. 
-- 
Questionnaire and Structured Interview Data for Client 1 
YBOCS- 7 
PRE- P0,ST- PRE- POST- FOLLOW- 
BT BT CT CT UP 
Table 10. 
Questionnaire and Structured Interview Data for Client 4 
BDDE 
YBOCS- 
BDD 
AS I 
OVlS 
SADS 
BDI-II 
PRE- 
BSL 
1 34 
32 
4.71 
8.50 
26 
40 
PRE- 
CT 
126 
34 
4.36 
9.13 
2 5 
40 
POST- 
CT 
120 
37 
3.79 
7.50 
26 
37 
FOLLOW- 
UP 
128 
30 
4.29 
8.88 
27 
32 
PRE- 
BT 
113 
35 
4.50 
8.63 
27 
43 
POST- 
BT 
128 
33 
4.50 
7.88 
27 
40 
Chapter 4 
DISCUSSION 
The current study utilized a multiple baseline, treatment crossover 
design to investigate the effects of cognitive and behavioral therapies on 
the reduction of BDD symptoms and the implications of these results on 
behavioral and cognitive theories of BDD symptom maintenance. 
Following a careful diagnostic screening, six individuals diagnosed with 
BDD as the primary disorder were invited to participate. Five participants 
completed the study. These participants received eight twice-weekly one- 
hour sessions of either behavior or cognitive therapy, followed by the 
same number of sessions of the other treatment. Although results 
demonstrated wide variability, behavior therapy appeared to be more 
effective in reducing daily ratings of negative thoughts, compulsive 
behaviors, and global distress. In addition, for three of the five 
participants, clinically significant improvement was demonstrated following 
the combination of both cognitive and behavior therapy. Results were 
more consistent with the behavioral theory of BDD symptom maintenance. 
Implications for Behavioral Theorv of BDD 
The current study investigated implications for behavioral theory of 
BDD symptom maintenance, which states that BDD rituals and avoidance 
responses are maintained through negative reinforcement. Through 
interrupting the reinforcing properties of the behaviors and allowing the 
habituation process to occur, overall frequencies of BDD-related 
behaviors were hypothesized to decrease. In addition, OCD outcome 
literature has demonstrated that ERP reduces OCD-related cognitions 
and associated distress. Thus, in the current study, ERP also was 
hypothesized to decrease the daily frequencies of negative appearance- 
related self-statements and overall distress levels. 
Results were consistent with behavioral theory. Following behavior 
therapy, one participant improved notably on all three daily measures of 
behaviors, thoughts, and distress, whereas another improved notably on 
the daily measure of behaviors. In addition, although both behavior 
therapy and cognitive therapy were hypothesized to be necessary for 
clinically significant improvement on questionnaire measures, behavior 
therapy alone demonstrated clinically significant decreases for two 
participants on the YBOCS-BDD, one of whom no longer met criteria for 
BDD following behavior therapy. Furthermore, although definitive 
conclusions cannot be made due to order effects, one client who received 
cognitive therapy as the initial treatment demonstrated clinically significant 
reductions in YBOCS-BDD and BDI-II scores only after behavior therapy 
had been introduced. Also, this individual no longer met criteria for BDD 
following the completion of behavior therapy. 
One of the three participants who received behavior therapy as the 
first treatment did not demonstrate improvement on any of the daily 
measures nor self-report questionnaires. Although this individual 
appeared to understand the therapeutic principles and to engage fully in 
treatment, she did not demonstrate symptom change. The reasons for 
this lack of improvement remain unclear. 
In summary, results make a case for the behavioral theory of BDD. In 
keeping with studies of behavior therapy for BDD (Marks & Mishan, 1988; McKay 
et at., 1997), the exposure to feared situations and the prevention of ritual 
completion often resulted in the reduction of daily compulsive behaviors, as well 
as related thoughts and distress. In addition, results are consonant with ERP 
outcome literature for OCD (Foa & Goldstein, 1978; Ito, et al., 1995; Lelliot, et 
al., 1988), which demonstrates effectiveness in reducing compulsions and, to a 
lesser degree, frequency of obsessions and strength of conviction in obsessional 
beliefs. Importantly, however, are the other theories of ERP that could 
potentially explain therapeutic effects. For instance, as previously mentioned, 
the success of behavior therapy also could be a consequence of an altered fear 
structure (Foa & Kozak, 1991), changes in cognitions, or improvements in self- 
efficacy (Bandura, 1986, 1988). Thus, although the current results are 
consistent with the behavioral model of BDD, a definitive conclusion regarding 
the impact of reinforcement contingencies cannot be drawn. 
Implications for Cognitive Theon/ of BDD 
The current study also investigated the cognitive theory of BDD 
symptom maintenance, which states that BDD symptoms are maintained 
through distorted thinking patterns and ongoing negative self-statements. 
Due to the interactive nature of cognition, behavior, and affect, the 
challenging of distorted assumptions was hypothesized to result in a 
decrease in daily negative self-statements, BDD-related behaviors, and 
associated distress. 
Results were partially consistent with cognitive theory. Following 
cognitive therapy, one participant improved notably on daily measures of 
thoughts, distress, and third party ratings of behavioral effort and 
reassurance-seeking. However, for this individual, decreases in daily 
behavioral avoidance were not exhibited as a result of cognitive therapy. 
In addition, clinically significant reductions on the YBOCS-BDD, BDDE, 
and BDI-II scores were not demonstrated until a course of ERP had been 
completed. Unfortunately, however, definitive conclusions regarding the 
separate effects of cognitive or behavior therapy on these particular 
improvements cannot be drawn due to order effects. 
The second participant who received cognitive therapy as the first 
treatment demonstrated no improvement on daily measures, self-report 
questionnaires, or the clinical interview. At the time of the study, this 
individual also was suffering from intense distress associated with 
extreme physical, verbal, and psychological abuse experienced in 
childhood. In addition, during the study, she charged her husband with 
physical assault (which was the culmination of years of physical abuse) 
and accidentally found her daughter attempting suicide/homicide through 
carbon monoxide poisoning by locking herself in the garage with her one 
year-old child. These additional factors were believed to be influential in 
the lack of treatment response by impeding therapeutic engagement. 
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This individual was too distressed to complete homework exercises and 
was often too distracted to fully engage in in-session therapeutic 
exercises. Thus, therapeutic success was thought to be impeded by 
these factors. 
In summary, results were somewhat consistent with the cognitive 
theory for BDD. The challenging of cognitive distortions improved daily 
negative self-statements and global distress for only one of two 
participants, and did not reduce daily avoidance or result in clinically 
significant improvement in self-report measures. Mixed results for 
cognitive therapy also were demonstrated in a previous BDD outcome 
study (Geremia, 1997). In that study, cognitive therapy resulted in a 
reduction in BDD-related thoughts and behaviors for only two of the four 
participants. It is important to realize, however, that poor treatment results 
do not necessarily refute the theory due to other potential impediments. 
For instance, in the current study, the opportunity for replication was not 
as available for the CT-BT condition because the third participant dropped 
out of the study following cognitive therapy and did not return any data. 
Therefore, the second replication available for the BT-CT condition was 
not possible. In addition, the complexity of cognitive therapy may require 
a much greater number of sessions before effectiveness is demonstrated. 
Although results have been interpreted within the cognitive model 
of BDD, the potential impact of other therapeutic factors prevents firm 
conclusions regarding the altering of maladaptive schemas. As previously 
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discussed, other theories have proposed crucial change mechanisms of 
effective cognitive therapy. For instance, an improved match between 
perceived threat and coping ability (McFall & Wollersheim, 1979), as well 
as a subsequent increase in behavioral activity (Abromowitz, 1997) have 
been hypothesized causes for improved symptoms following cognitive 
therapy. Thus, a firm conclusion supporting cognitive theory of BDD could 
not have been possible in this study. 
Response Covariation 
Predictions were also made regarding the covariation of BDD- 
related thoughts and behaviors. As previously discussed, response 
covariation during cognitive and behavior therapies has been 
demonstrated in a preliminary manner (Geremia, 1997; Marks & Mishan, 
1988). However, this research has focused on pre-post or periodic 
measurements with self-report measures. The current study is the first to 
examine fluctuations in daily thoughts and behaviors over baseline and 
treatment phases. 
Evidence for daily covariation of intrusive thoughts and compulsive 
behaviors/avoidance was mixed. Two participants demonstrated strong 
covariation of thoughts and behaviors over both baseline and treatment 
phases. Client 3 exhibited similar fluctuations in thoughts and behaviors 
during baseline, followed by a gradual decrease in both over the course of 
behavior therapy. Thus, for this individual, behavior therapy was sufficient 
in reducing compulsive mirror-checking as well as negative self- 
statements. In addition, the strong connection between thoughts and 
behaviors may be seen during the following phase of cognitive therapy, in 
which a 45-day absence of both negative self-statements and mirror- 
checking was interrupted by a one-day rise in both thought and behavior 
scores. Although Client 1 did not improve notably throughout the study, 
the link between mirror-checking and negative self-statements was clearly 
demonstrated. Daily scores for both thoughts and behaviors fluctuated 
widely throughout baseline and treatment phases, with increases and 
decreases in one score closely following the other. 
None of the other three participants demonstrated a clear 
covariation between thoughts and behaviors. Client 2 exhibited a 
decrease in distracting behaviors over the course of behavior therapy, 
which remained throughout the following baseline and cognitive therapy 
treatment phase. However, negative self-statements did not notably 
decrease over the course of the study. For Client 5, although negative 
self-statements and third party ratings of behavioral effort decreased over 
the course of cognitive therapy, levels of avoidance behaviors remained 
relatively stable. In addition, over the subsequent course of behavior 
therapy, levels of avoidance decreased slightly while negative self- 
statements slightly increased. Finally, Client 4 did not demonstrate 
improvement over the course of the study. 
Traditionally, and in this study, competing cognitive and behavioral 
theories of treatment success have been discussed as separate and 
distinct theoretical models. However, reports of the relatively equal 
effectiveness of ERP and cognitive therapy in the treatment of OCD 
(Emmelkamp & Beens, 1991; Emmelkamp, et al., 1988; van Oppen et al., 
1995) have led to speculation regarding mechanisms of change and the 
validity of such separate theoretical distinctions. Abromowitz (1 997) 
suggested two possible explanations. One possibility is that behavior 
therapy and cognitive therapy achieve similar effects through specific and 
separate psychological mechanisms. Alternately, these two treatments, 
considered to be from separate theoretical approaches, may actually 
share a common psychological mechanism. It has been suggested that 
the separate mechanisms approach would be supported if cognitive 
therapy resulted in significantly more cognitive than behavioral change, 
and vice versa (Abromowitz, 1997). Currently, available data do not 
support the existence of separate mechanisms for OCD. Likewise, the 
covariation demonstrated in the present study does not support the idea 
of separate mechanisms for BDD. 
Effects of Combined Cosnitive-Behavioral Treatment 
In keeping with BDD outcome research, three participants 
demonstrated improvement in several domains following the completion of 
both cognitive and behavioral treatments. At post-CBT and a two-month 
follow-up, Client 5 no longer met criteria for BDD and demonstrated 
clinically significant reductions on measures of BDD symptom severity and 
depression. In addition, daily measures of negative cognitions and global 
distress, as well as third party assessments of behavioral effort and 
reassurance-seeking decreased notably over the course of CBT. At post- 
CBT and follow-up, Client 2 demonstrated clinically significant decreases 
on measures of BDD symptom severity and depression and, at follow-up, 
no longer met criteria for BDD. In addition, Client 2 demonstrated a 
notable reduction in daily frequencies of compulsive behaviors. Finally, at 
post-CBT, Client 3 exhibited notable decreases in daily measures of 
negative cognitions, compulsive behaviors, and global distress, and no 
longer met criteria for BDD. The remaining two participants did not 
improve during the study. 
The results of this study provide previously unknown information 
regarding the necessary components of CBT. Because cognitive and 
behavioral therapies were conducted separately and in succession, 
effects of the first-order treatment versus the combined treatment may be 
evidenced. Of the three participants who improved, behavior therapy 
appeared to be the pivotal component in effecting clinically significant 
change. The improvements gained by Client 2 and Client 3 on 
questionnaires of symptom severity and daily measures of cognition, 
behavior, and distress were largely demonstrated following the completion 
of behavior therapy as the initial treatment and maintained through the 
course of cognitive therapy. Client 5, who received behavior therapy as 
the second treatment, demonstrated clinically significant change on 
measures of BDD symptoms and depression only once behavior therapy 
106 
had been completed. Unfortunately, definitive conclusions regarding the 
cause of those particular improvements cannot be drawn, as the reduction 
of symptoms could be attributable to either the introduction of behavior 
therapy or carry-over effects of cognitive therapy. However, the 
information provided by Client 5 is consistent with results from the 
additional two participants, which appear to support the behavioral 
therapy of BDD. 
Thus, although some evidence supporting cognitive therapy was 
demonstrated, the current study lends more support to the behavioral 
therapy of BDD. 
Relation To Other Studies 
Results of the current study were consistent with many published 
findings. First, as with several studies of CBT (Neziroglu & Yaryura- 
Tobias, 1993; Neziroglu et al., 1996; Rosen et al., 1995; Wilhelm, 1999), 
the combined effects of cognitive challenging and ERP improved BDD 
symptoms and depression for some individuals. Due to the use of several 
commonly used measures (e.g., BDDE, YBOCS-BDD, and BDI-II), similar 
rates of improvement following CBT are exhibited between the current 
study and previous research (Neziroglu & Yaryura-Tobias, 1993; 
Neziroglu et al., 1996; Rosen et al., 1995; Wilhelm, 1999). In addition, the 
resistance to treatment demonstrated in the above studies, has been 
replicated here. Current results are consistent with discussions 
(Neziroglu, 2000) regarding minimal results often obtained despite high 
numbers of treatment sessions. 
The current data also mirror preliminary results on the effects of 
ERP and cognitive therapy as separate treatments. McKay and 
colleagues demonstrated that ERP alone is sufficient in reducing BDD 
symptoms and depression (McKay et al, 1997). Although the current 
study cannot claim to show symptom reduction in all participants, 
consistency can be concluded through the ability of ERP alone to reduce 
BDD and depressive symptoms in two out of three individuals. In 
addition, similarity with Geremia (1 997) may be seen in the lesser effects 
of cognitive therapy as a sole treatment. Although cognitive therapy did 
result in some daily symptom reduction for one client, it did not lead to any 
clinically significant decreases on the YBOCS-BDD or other self-report 
measures. Similarly, in Geremia's study, only one of four participants 
improved on YBOCS-BDD scores following cognitive therapy. Thus, 
results of the present study are consistent with both treatment 
improvements and treatment challenges recorded in the outcome 
literature. 
Mechanisms of Change 
In an attempt to identify potential mechanisms for therapeutic 
improvement (i.e., decreases in thoughts or behaviors), the daily changes 
occurring during successful treatment were examined. Of the three 
participants who improved to a clinically significant degree, each exhibited 
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a different pattern of daily symptom improvement. Following CBT, Client 
2 did not meet criteria for BDD and demonstrated clinically significant 
reductions in YBOCS-BDD and BDI-II scores. During treatment, he 
recorded notable decreases in compulsive behaviors but no such 
reduction in negative self-statements. Following behavior therapy, Client 3 
no longer met BDD criteria and demonstrated clinically significant 
improvement in YBOCS-BDD scores. Congruently, he also recorded 
notable reductions in daily thoughts and behaviors. Surprisingly, however, 
he lost these gains in clinically significant improvement during cognitive 
therapy and follow-up, but maintained the decrease in daily thoughts and 
behaviors. Finally, following CBT, Client 5 did not meet criteria for BDD 
and demonstrated clinically significant improvement in YBOCS-BDD and 
BDI-II scores. During treatment, she recorded decreases in daily negative 
self-statements but no notable improvements in avoidance behaviors. 
Given the inconsistent patterns of change across participants, no 
generalized conclusions can be drawn regarding the mechanisms for BDD 
symptom change. It appears as if different mechanisms may operate for 
different individuals. Anecdotally, clients have been reported to 
demonstrate little reduction in BDD-related thoughts coincident with 
successful treatment, but instead report a decrease in negative meaning 
attached to those thoughts (Neziroglu. 2000). Thus, perhaps a decrease 
in negative self-statements is an indicator of success for some, but for 
others it is the ability to think "my nose is big and ugly, but who cares?" 
Another possibility is a lack of connection between negative self- 
statements and compulsive behaviors, such that a decrease in distress- 
provoking thoughts leads to clinically significant improvement but allows 
for some compulsive behaviors to remain. For others who demonstrate a 
decrease in daily thoughts and behaviors but who still meet criteria for 
BDD, the important factor may be the ability of the remaining cognitions 
and rituals to create intense distress. In this case, the change mechanism 
would not be frequency reduction but perhaps affective reduction. These 
issues remain unclear. 
Sensitivitv of Measures 
Although improvements were demonstrated by several participants 
on behavioral, cognitive, and affective measures, such progress was not 
reflected by other self-report questionnaires employed in the study. This 
raises questions regarding the sensitivity of those measures. For 
example, no improvements in AS1 scores were demonstrated by any 
participant. The AS1 was designed to assess beliefs and assumptions 
concerning the importance, meaning, and effects of appearance on one's 
life. Despite the fact that all participants exhibited clinically significant 
distress and impairment stemming from appearance-related concerns, 
three of the five participants' pre-treatment scores fell within the normal 
range. Further examination revealed that the normative data for the AS1 
were obtained from a sample of female college students, which may have 
inflated the mean artificially. Therefore, the AS1 may not have been an 
appropriate measure of BDD treatment change. 
Despite obvious gains in social and occupational functioning for 
several participants, clinically significant improvements were not 
demonstrated on the SADS, a measure designed to assess distress and 
avoidance associated with social and interpersonal situations. For 
example, prior to treatment, Client 3 had been virtually housebound and 
rarely left his bedroom for fear of being seen by others. He had 
discontinued post-secondary education and had recently been divorced 
due to appearance-related difficulties. During the final treatment 
sessions, he made regular trips to a music store, went out on a date, and 
re-enrolled in school. The SADS failed to detect these changes in social 
functioning. Perhaps the general, trait-like items, such as "I tend to 
withdraw from people" or "I feel relaxed even in unfamiliar situations," are 
incapable of detecting more specific, yet clinically significant, changes in 
social and interpersonal functioning. An additional difficulty with the 
SADS is the rectangular distribution and large standard deviation found in 
the normal sample, which prevents the clinical significance criteria (i.e., 
the post-treatment score must be two standard deviations below the mean 
of the normal sample) from being met. 
Finally, the detection of daily change for Client 5 was hampered by 
the particular nature of her symptom presentation. Whereas other 
participants experienced higher frequencies of thoughts, Client 5 
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experienced fewer but extremely distressing self-statements regarding her 
appearance and self-worth. This floor effect hindered the demonstration 
of more dramatic reductions in daily negative thoughts. In addition, the 
determination of a measurable daily behavior was not possible because 
she did not engage in any overt rituals such as mirror-checking. 
Therefore, an inverse measure of daily avoidance was chosen, which may 
have affected the ability to demonstrate reliable reductions. 
Limitations of the Studv 
Inherently present in crossover designs, order effects result in 
methodological limitations for treatment studies. Due to the fact that the 
initial treatment is followed by a second type of therapy, it is uncertain 
whether effects demonstrated in the second phase are due to the second 
treatment or to delayed effects of the initial intervention. Conclusions can 
only be drawn regarding the effect of the first treatment and the effect of 
the two treatments combined. Therefore, in the current study, 
interpretations regarding cognitive therapy cannot be made for Clients 1 
through 3 who received behavior therapy as their initial treatment. 
Likewise, results from Client 4 and Client 5 cannot provide information on 
the effects of behavior therapy alone. However, the crossover design is 
ideal for comparing the initial treatments to the package intervention and 
was, therefore, chosen as an important component of the current design. 
As discussed previously, one important benefit of the multiple 
baseline design is the increase in confidence it provides in drawing 
conclusions. Unlike single-phase change designs, multiple baselines 
provide protection against time- and environmentally-related effects. 
Thus, the varying baselines allow for greater confidence in interpreting 
post-baseline symptom improvement. Unfortunately, in the current study, 
baseline data sometimes demonstrated wide variability and occasional 
decreases in scores. Although this could arguably detract from the 
interpretation of results, the severity and long-term nature of these 
individuals' symptoms provides support for treatment effectiveness. For 
example, Client 3 demonstrated wide variability in frequency of negative 
self-statements, with a moderate decrease toward the end of the three- 
week baseline period. The remote potential of spontaneous improvement 
exists. However, severe BDD symptoms had been present for at least 
seven years and had led to suicide attempts and inpatient 
hospitalizations. In addition, he had experienced little relief following 
seven years of pharmacotherapy and numerous courses of supportive 
counseling. Therefore, a more likely interpretation of the baseline 
decrease could be an increased sense of hope or self-efficacy due to the 
preliminary participation in the study or contact with a mental health 
professional who understood a frequently unrecognized disorder. The 
ineffectiveness of previous supportive counseling argues against the 
influence of nonspecific effects in the symptom reduction demonstrated 
following behavior therapy. 
Treatment Failures 
Although improvements were demonstrated in several realms, the 
present results concur with recent outcome literature in the varied and 
inconsistent nature of treatment success. Two participants did not 
improve on any of the outcome measures. Possible explanations for this 
lack of improvement have been discussed above. Client 2 did not 
improve on daily measures of negative thoughts or global distress, 
whereas Client 5 did not improve on daily measures of behaviors. Client 
3 no longer met criteria for BDD and demonstrated clinically significant 
improvement on the YBOCS-BDD following a course of behavior therapy 
but that improvement was lost and never regained once treatment 
switched to cognitive therapy. In addition, Client 3 never demonstrated 
clinically significant improvement on a measure of depression. 
Previous treatment studies of BDD have revealed similar patterns 
(Geremia, 1997; Neziroglu et al., 1996; Rosen et al., 1995; Veale et al., 
1996; Wilhelm et al., 1999). In addition, it has been noted that statistically 
significant improvement in BDD symptoms is an insufficient criterion for 
treatment success, due to the extremely high scores on outcome 
measures and the debilitating nature of symptoms (Neziroglu, 2000). 
Thus, the more meaningful, and sometimes more stringent, criterion of 
clinically significant improvement has been recommended. Perhaps the 
focus on clinically significant changes in the current study may explain the 
varied results on questionnaire measures. 
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Clinical Implications 
Although behavior therapy appears to be more effective in reducing BDD 
symptoms and related difficulties, cognitive treatment also has been 
demonstrated to result in some therapeutic change. This is important knowledge 
due to the aversive nature of exposure therapy and clients' frequent reluctance 
or refusal to participant (Newell & Shrubb, 1994). Preliminary findings regarding 
cognitive therapy suggest that such an approach would be a viable option for 
clients refusing to engage in exposure exercises. In addition, cognitive therapy 
may be viewed as an appropriate strategy for initial sessions, to allow for rapport- 
building and for reducing the rigidity of beliefs that may be preventing the 
acceptance of behavior therapy. One client from the current study who had 
received cognitive therapy as the first treatment stated that she would not have 
been willing to engage in exposure exercises prior to cognitive treatment. She 
stated that challenging the cognitive distortions provided evidence against the 
catastrophic conclusions, and that she was able to draw on that evidence to gain 
strength for exposure trials. Of course, these conclusions were retrospective. 
Conclusions 
The present study was the first to explore behavioral and cognitive 
theories of symptom maintenance, and the first to examine daily changes 
in thoughts, behaviors, and affect during behavior and cognitive therapy of 
BDD. Results were consistent with the behavioral theory of BDD 
symptom maintenance. For two out of three participants, interrupting the 
reinforcing properties of ritual and avoidance behaviors and allowing the 
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natural course of habituation to take place resulted in a decrease in daily 
BDD-related symptoms. In addition, selected results were consistent with 
the cognitive maintenance theory. For one of the two participants, the 
challenging of cognitive distortions and negative automatic thoughts led to 
a more limited decrease in some daily symptoms. Although these results 
have been interpreted within specific behavioral and cognitive 
frameworks, they do not refute other interpretations of symptom 
maintenance. 
Results of the combined CBT package replicated previous BDD 
outcome studies. Following the completion of both treatments, three of 
the five no longer met criteria for the disorder, and two maintained this 
improvement at a two-month follow-up. In addition, two of the five 
demonstrated clinically significant reductions on measures of BDD 
symptoms and depression. A third participant also achieved a clinically 
significant decrease on the BDD symptom measure, but lost those gains 
once treatment was switched from behavior to cognitive therapy. 
Behavior therapy appeared to be the more important component in 
effecting clinically significant improvement. 
For most clients, the covariation of BDD-related thoughts and 
behaviors was demonstrated across baseline and treatment phases. This 
information is very useful for the treatment of BDD, due to the strength of 
conviction often exhibited in BDD-related beliefs. For one client, ERP 
alone was sufficient in drastically reducing negative appearance-related 
self-statements. Finally, results were inconclusive regarding the 
mechanism of change in successful BDD treatment. 
Future Directions 
The current study involved a total of 16 one-hour sessions held 
twice per week and broken down into eight behavior therapy and eight 
cognitive therapy sessions. Although this design was chosen to 
investigate the relative effects of cognitive and behavior therapy 
compared to the combined package, the total number of sessions per 
modality may have been too abbreviated. Future designs examining daily 
changes in symptoms could include a behavior therapy condition andlor a 
cognitive therapy condition to allow investigations of a more complete 
course of each therapy. For example, rather than implementing a 
prescribed number of sessions, behavior therapy could be conducted until 
changes in compulsive behaviors occur. Likewise, a parallel condition 
could provide cognitive therapy until changes in negative self-statements 
are demonstrated. Such an investigation would prevent a premature 
termination of the treatment that could mask imminent effects, allowing 
sufficient time for the identification of delayed treatment changes. In 
addition, this type of design would enhance ecological validity, as it would 
more likely reflect the delivery of treatment in a non-research setting. 
Due to the high rate of BDD treatment failures, valuable information 
could be provided by an intensive study of participants who did not 
improve. In the current study, two individuals failed to demonstrate 
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therapeutic changes, and possible explanations were discussed regarding 
treatment engagement. Therefore, one potential approach would be to 
examine treatment failures in terms of their ability to understand treatment 
rationales and their ability to engage fully in the treatment at home and in 
session. This could assist in determining whether therapeutic 
engagement is a frequent impeding factor, or whether other factors 
interfere with treatment once the client has engaged. 
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Appendix A 
Some Critical Interview Items on the BDDE 
Has there been anything about your physical appearance which 
you disliked over the past four weeks? 
Over the past four weeks, to what extent have you felt that other 
people have the same feature? 
Over the past four weeks, have you inspected your in order to 
check the extent of the problem? 
Over the past four weeks, how dissatisfied with your have 
you felt? Have there been days that you have been so dissatisfied it 
has upset you? 
Over the past four weeks, how dissatisfied with your appearance overall 
have you felt? 
Over the past four weeks, have you tried to get reassurance from others 
that your is not as bad or abnormal as you think it is? 
Over the past four weeks, have you spent much time thinking about your 
and feeling upset? 
Over the past four weeks, how much have you worried about your 
when you were in public areas? 
Over the past four weeks, how much have you worried when you were in 
social settings? 
1 0. Over the past four weeks, how often have you felt that other people were 
noticing or paying attention to your ? 
I I. Over the past four weeks, how upset have you become when you felt 
someone was noticing or paying attention to your ? 
12. Over the past four weeks, how often has someone made either a positive 
or negative comment on your ? 
1 3. Over the past four weeks, how upset have you become when someone 
commented on your ? 
14. Over the past four weeks, how often have you been treatment differently 
by others or in ways you didn't like because of your ? 
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15. Over the past four weeks, how upset have you become when people 
treated you in these ways because of your ? 
16. Over the past four weeks, has your influenced how you think about 
yourself as a person? 
17. Over the past four weeks, have you ever gotten down on yourself or felt 
negatively about yourself as a person because of your ? 
18. Over the past four weeks, did you ever feel other people judged you 
negatively because of your ? 
19. Over the past four weeks, how attractive physically do you feel other 
people thought you were? 
20. Over the past four weeks, have you ever thought that your might 
not be as bad as you generally think? 
21. Over the past four weeks, have you avoided public areas because you felt 
uncomfortable about your ? 
22. Over the past four weeks, have you avoided work or social situations 
because you felt uncomfortable about your ? 
23. Over the past four weeks, have you avoided close physical contact with 
others because of your . 
24. Over the past four weeks, have you deliberately dressed in any way to 
cover up or disguise your ? 
25. Over the past four weeks, have you deliberately controlled your posture or 
body movements in order to hide your ? 
26. Over the past four weeks, have you compared your with the 
appearance of other people around you or in magazines or television? 
Appendix B 
Participants' Behavioral Measures for the TCBS 
Participant 1 : Number of mirror-checks conducted from 9:OOAM to 
10:OOAM 
Participant 2: Number of distracting behaviors (e.g., covering 
mouth, excessive talking, turning head) completed 
during the entire day 
Participant 3: 
Participant 4: 
Participant 5: 
Number of mirror-checks conducted from 12:OOAM to 
1 :00AM 
Number of minutes spent mirror-checking from 
1 0:OOAM to 1 1 :00 AM 
Amount of avoidance for entire day - measured by 
computing the inverse of the number of leisurelfun 
activities conducted in public that day 
Appendix C 
Third Partv Form 
ID #: 
Date: 
Number of times today that your family memberlfriend has sought 
reassurance about hislher appearance: 
Please rate how much effort this week that your family memberlfriend has 
put into behaviors related to hislher appearance. 
no little moderate much extreme 
effort effort effort effort effort 
Appendix D 
Yale-Brown Obsessive Compulsive Scale 
Body Dvsmorphic Disorder Version 
For each item, please circle the number that best describes the way you have felt 
andlor behaved over the past week, including today. 
1. On average, how much of your time during a given day is ocupied by 
thoughts about a defect or flaw in your appearance or body parts such as 
your hair, breasts, skin, teeth, genitals, hands, etc.? 
0 - None (symptom free) 
1 - Mild (less than 1 hour per day), or occasional thoughts 
(occurring no more than 8 timeslday) 
2 - Moderate (1-3 hours per day), or frequent thoughts (occurring 
more than 8 times per day) 
3 - Severe (3-8 hours per day), or very frequent thoughts 
(occurring more than 8 times per day and during most hours of 
the day) 
4 - Extreme (more than 8 hours per day), or near constant 
thoughts (too numerous to count and an hour rarely passes 
without several such thoughts occurring) 
2. How much do these thouqhts interfere with your social or work functioning? 
Is there anything you don't do because of them? 
0 - None (no recognizable interference) 
1 - Mild (slight interference with social or occupational functioning, 
but overall performance is not impaired) 
2 - Moderate (thoughts are frequent and disturbing, but still 
manageable) 
3 - Severe (thoughts cause substantial impairment in social or 
occupational functioning) 
4 - Extreme (incapacitating) 
3. How much distress do your thoughts about having appearance defects 
cause? 
0 - None (thoughts about body defects do not affect how I feel) 
1 - Mild (thoughts are not very disturbing) 
2 - Moderate (thoughts are frequent and disturbing, but still 
manageable) 
3 - Severe (thoughts are very frequent and very disturbing) 
4 - Extreme (incapacitating) 
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4. How much of an effort do you make to resist these thoughts? How often do 
you try to resist or turn your attention away from these thoughts as they enter 
your mind? 
0 -Always try to resist these thoughts, or symptoms are so minimal 
that it is not necessary to resist. 
1 -Try to resist most of the time 
2 - Make some effort to resist 
3 - Yield to all such thoughts'without attempting to control them, 
but do so with some reluctance 
4 - Completely and willingly yield to all such thoughts 
5. How much control do you have over your thoughts about your 
appearance defects? How successful are you in stopping or diverting 
these thoughts? 
0 - Complete control 
1 - Much control, thoughts are stopped or diverted with some effort 
or concentration 
2 - Moderate control, sometimes able to stop or divert these 
thoughts 
3 - Little control, rarely able to stop or divert these thoughts 
4 - No control, completely out of control, thoughts are experienced 
as involuntary and automatic 
6. How much time do you spend in activities related to your concern over your 
appearance or bodily defect (e.g., time spent trying to conceal the defect with 
makeup, consulting plastic surgeons or dermatologists, looking in the mirror, 
etc.) 
0 - No time spent in these behaviors 
1 - Mild (spend less than one hour per day in these activities) 
2 - Moderate (1-3 hours per day, or no more than 8 times per day) 
3 - Severe ( 3-8 hours per day), or frequent involvement (more 
than 8 times per day) 
4 - Extreme (more than 8 hours per day spent on these activities, 
or near constant involvement) 
7. How much do these activities interfere with your social or work functioning? 
Is there anything you don't do because of them? 
0 - None (no interference) 
1 - Mild (slight interference with social or occupational functioning, 
but overall performance is not impaired) 
2 - Moderate (definite interference with social or occupational 
functioning, but still manageable) 
3 - Severe (activities cause substantial impairment in social or 
occupational functioning) 
4 - Extreme (incapacitating) 
8. How would you feel if prevented from performing these activities (e-g., no 
mittor-checking, makeup, camouflaging, consulting plastic surgeons or 
dermatologists, etc.)? How distressed would you become? 
0 - No distress 
1 - Mild (would feel slightly anxious if such behaviors were 
prevented) 
2 - Moderate (anxiety would mount but remain manageable if such 
behaviors were prevented) 
3 - Severe (prominent and very disturbing increase in anxiety 
would result of behaviors were prevented) 
4 - Extreme (incapacitating anxiety would result from any 
intervention aimed at modifying these behaviors) 
9. How much of an effort do you make to resist these behaviors? 
0 - Always try to resist these compulsions 
1 - Try to resist most of the time 
2 - Make some effort to resist 
3 - Yield to almost all of these behaviors without attempting to 
control them 
4 - Completely and willingly yield to all behaviors related to 
perceived appearance defect 
10. How strong is the drive to perform these behaviors? How much control do 
you have over them? 
0 - Complete control 
1 - Much control, able to exercise voluntary control over these 
behaviors 
2 - Moderate control, able to control these behaviors with some 
difficulty 
3 - Little control. very strong drive to perform these behaviors, can 
delay these behaviors with considerable difficulty 
4 - No control, completely and willingly yield to all behaviors 
related to perceived appearance defect 
Appendix E 
AS Inventory 
Indicate your beliefs about these items using the 1 to 5 scale: 
Strongly Mostly Neither Disagree Mostly Strongly 
Disagree Disagree Nor Agree Agree Agree 
1. What I look like is an important part of who I am. 1 2 3 4 5  
2. What's wrong with my appearance is one of the first 
things people will notice about me. 1 2 3 4 5  
3. One's outward physical appearance is a sign of the 
character of the inner person. 1 2 3 4 5  
4. If I could look just as I wish, my life would be mush happier. 1 2 3 4 5 
5. If people knew how I really look, they would like me less. 1 2 3 4 5  
6. By controlling my appearance, I can control many of the 
social and emotional events in my life. 1 2 3 4 5  
7. My appearance is responsible for much of what has 
happened to me in my life. 1 2 3 4 5  
8. 1 should do whatever I can to always look my best. 1 2 3 4 5  
9. Aging will make me look less attractive. 1 2 3 4 5  
10. For women: To be feminine, a woman must be as pretty 
as possible. 
For men: To be masculine, a man must be as handsome 
as possible. 1 2 3 4 5  
11. The media's messages in our society make it impossible 
for me to be satisfied with my appearance. 1 2 3 4 5  
12. The only way I could ever like my looks would be to change 
what I look like. 1 2 3 4 5  
13. Attractive people have it all. 1 2 3 4 5  
14. Homely people have a hard time finding happiness. 1 2 3 4 5  
Appendix F 
Social Avoidance and Distress Scale 
Please read each question and circle either T (true) or F (false). 
1. I feel relaxed even in unfamiliar situations. T/F 
2. 1 try to avoid situations which force me to be sociable. T/F 
3. It is easy for me to relax when with strangers. TIF 
have no particular desire to avoid people. TIF 
often find social occasions upsetting. T/F 
usually feel calm and comfortable in social situations. TIF 
I am usually at ease when talking to someone of the opposite sex. TIF 
8. 1 try to avoid talking to people unless I know them well. TIF 
9. If the chance comes to meet new people, 1 often take it. TIF 
10. 1 often feel nervous or tense in casual get-togethers in which both sexes are 
present. TIF 
11. 1 am usually nervous with people unless I know them well. TIF 
12. 1 usually feel relaxed when I am with a group of people. TIF 
13. 1 often want to get away from people. TIF 
14. 1 usually feel comfortable when I am in a group of people I don't know. TIF 
15. 1 usually feel relaxed when I meet someone for the first time. T/F 
16. Being introduced to people makes me feel tense and nervous. TIF 
17. Even though a room is full of strangers, I may enter it anyway. TIF 
18. 1 would avoid walking up and joining a large group of people. TIF 
19. When superiors want to talk to me, I talk willingly. T/F 
20. 1 often feel on edge when I am with a group of people. TIF 
21. 1 tend to withdraw from people. TIF 
22. 1 don't mind talking to people at parties or social gatherings. TIF 
23. 1 am seldom at ease in a large group of people. T/F 
24. 1 often think up excuses in order to avoid social engagements. TIF 
25. 1 sometimes take the responsibility for introducing people to one 
another. TIF 
26. 1 try to avoid formal social gatherings. T/F 
27. 1 usually go to whatever social engagements I have. TIF 
28. 1 find it easy to relax with other people. TIF 
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Appendix G 
Overvalued Ideas Scale 
List three of the main appearance related beliefs you have had in the past week 
(e-g., I am unattractive, my nose is misshapen, my complexion is ruddy, etc.) 
Please read each of the following questions. Rate each belief separately 
according to the scale provided. 
1. How strong is each belief? 
< I  -2-3-4-5-6-7-8-9-7 O> 
not very strong very strong 
Belief # I  Rating 
Belief #2 Rating 
Belief #3 Rating 
2. How reasonable is each belief? 
< I  -2-M-5-6-7-8-9-1 O> 
not very strong very strong 
Belief # I  Rating 
Belief #2 Rating 
Belief #3 Rating 
3. In the last week, what was the lowest rating for each belief? 
<I-2-%5+7-&-%I O> 
not very strong very strong 
Belief # I  Rating 
Belief #2 Rating 
Belief #3 Rating 
4. In the last week, what was the highest rating for each belief? 
< I  -2-34-5-6-7-8-9-10> 
not very strong very strong 
Belief # I  Rating 
Belief #2 Rating 
Belief #3 Rating 
5. How accurate or reality based is each belief? 
< 1 -2-345--6--7-8-9-10> 
not very strong very strong 
Belief # I  Rating 
Belief #2 Rating 
Belief #3 Rating 
6. How likely is it that others have the same belief about your appearance that 
you do? 
< 1 -2-34-54-7-8-%I 07 
not very strong very strong 
Belief # I  Rating 
Belief #2 Rating 
Belief #3 Rating 
7. What is the likelihood that your compulsive (beautification remedies, 
avoidance behaviors, mirror-checking, etc.) being effective in changing the 
way you feel? 
< 1-2-345-6-7-8-9-1 07 
not very strong very strong 
Belief # I  Rating 
Belief #2 Rating 
Belief #3 Rating 
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8. Compared to others, how unusual is each of your beliefs? (How likely is it 
that others have the same belief about themselves that you have about 
yourself?) 
< 1 -2-34-5-&7-&9-1 O> 
not very strong very strong 
Belief #1 Rating 
Belief #2 Rating 
Belief #3 Rating 
Appendix H 
Items from the Beck Depression Inventory 
1. Sadness 
0 I do not feel sad 
1 I feel sad much of the time 
2 1 am sad all the time 
3 1 am so sad or unhappy that I can't stand it 
2. Pessimism 
0 I am not discouraged about my future 
1 I feel more discouraged about my future than I used to be 
2 1 do not expect things to work out for me 
3 1 feel my future is hopeless and will only get worse 
3. Past Failure 
0 I do not feel like a failure 
1 I have failed more than I should have 
2 As I look back, I see a lot of failures 
3 1 feel I am a total failure as a person 
4. Loss of Pleasure 
0 I get as much pleasure as I ever did from the things I enjoy 
1 I don't enjoy things as much as I used to 
2 1 get very little pleasure from the things I used to enjoy 
3 1 can't get any pleasure from the things I used to enjoy 
5. Guilty Feelings 
0 I don't feel particularly guilty 
1 I feel guilty over many things I have dome or should have done 
2 1 feel quite guilty most of the time 
3 1 feel guilty all of the time 
6. Punishment Feelings 
0 I don't feel I am being punished 
1 I feel I may be punished 
2 1 expect to be punished 
3 1 feel I am being punished 
7. Self-Dislike 
0 I feel the same about myself as ever 
1 I have lost confidence in myself 
2 1 am disappointed in myself 
3 1 dislike myself 
8. Self-criticalness 
0 I don't criticize or blame myself more than usual 
1 I am more critical of myself than I used to be 
2 1 criticize myself for all of my faults 
3 1 blame myself for everything bad than happens 
9. Suicidal Thoughts or Wishes 
0 I don't have any thoughts of killing myself 
1 I have thoughts of killing'myself, but I would not carry them out 
2 1 would like to kill myself 
3 1 would kill myself if I had the chance 
10. Crying 
0 I don't cry anymore than I used to 
1 I cry more than I used to 
2 1 cry over every little thing 
3 1 feel like crying but I can't 
11. Agitation 
0 I am no more restless or wound up than usual 
1 I feel more restless or wound up than usual 
2 1 am so restless or agitated that it's hard to stay still 
3 1 am so restless or agitated that 1 have to keep moving or doing 
something 
12. Loss of Interest 
0 I have not lost interest in other people or activities 
1 I am less interested in other people or things than before 
2 1 have lost most of my interest in other people or things 
3 It's hard to get interested in anything 
13. Indecisiveness 
0 I make decisions about as well as ever 
1 I find it more difficult to make decisions than usual 
2 1 have much greater difficulty in making decisions than I used to 
3 1 have trouble making nay decisions 
14. Worthlessness 
0 I do not feel I am worthless 
1 I don't consider myself as worthwhile and useful as I used to 
2 1 feel more worthless as compared to other people 
3 1 feel utterly worthless 
15. Loss of Energy 
0 I have as much energy as ever 
1 I have less energy than I used to have 
2 1 don't have enough energy to do very much 
3 1 don't have enough energy to do anything 
16. Changes in Sleeping Pattern 
0 I have not experienced any change in my sleeping pattern 
1 a I sleep somewhat more than usual 
1 b I sleep somewhat less than usual 
2a I sleep a lot more than usual 
2b I sleep a lot less than usual 
3a I sleep most of the day 
3b I wake up 1-2 hours early and can't get back to sleep 
17. Irritability 
0 I am no more irritable than usual 
1 I am more irritable than usual 
2 1 am much more irritable than usual 
3 1 am irritable all the time 
18. Changes in Appetite 
0 I have not experienced any change in my appetite 
l a  My appetite is somewhat less than usual 
1 b My appetite is somewhat greater than usual 
2a My appetite is much less than before 
2b My appetite is much greater than before 
3a I have no appetite at all 
3b I crave food all the time 
19. Concentration Difficulty 
0 I can concentrate as well as ever 
1 I can't concentrate as well as usual 
2 It's hard to keep my mind on anything for very long 
3 1 fond I can't concentrate on anything 
20. Tiredness or Fatigue 
0 I am no more tired or fatigued than usual 
1 I get more tired or fatigues more easily than usual 
2 1 am too tired or fatigued to do a lot of things I used to do 
3 1 am too tired or fatigued to do most of things I used to do 
21. Loss of Interest in Sex 
0 I have not noticed any recent change in my interest in sex 
1 I am less interested in sex than I used to be 
2 1 am much less interested in sex now 
3 1 have lost interest in sex completely 
Appendix I 
Treatment Conditions 
CONDITION 1: 
Client # 
1 Baseline -- Behavior Therapy -- Baseline -- Cognitive Therapy 
(1 week) (4 weeks/ (3 weeks) (4 weeks1 
8 sessions) 8 sessions) 
2 Baseline -- Behavior Therapy -- Baseline -- Cognitive Therapy 
(2 weeks) (4 weeks/ (2 weeks) (4 weeks/ 
8 sessions) 8 sessions) 
3 Baseline -- Behavior Therapy -- Baseline -- Cognitive Therapy 
(3 weeks) (4 weeks/ (1 week) (4 wee ksl 
8 sessions) 8 sessions) 
CONDITION 2: 
Client # 
4 Baseline --- Cognitive Therapy -- Baseline -- Behavior Therapy 
(1 week) (4 weeks/ (3 weeks) (4 weeks/ 
8 sessions) 8 sessions) 
5 Baseline -- Cognitive Therapy -- Baseline -- Behavior Therapy 
(2 weeks) (4 weeks/ (2 weeks) (4 wee ksl 
8 sessions) 8 sessions) 
6* Baseline -- Cognitive Therapy -- Baseline -- Behavior Therapy 
(3 weeks) (4 weeks/ (1 week) (4 weeks1 
8 sessions) 8 sessions) 
* drop-out 
Appendix J 
Points of Assessment 
(Al*) Baseline (A2) Treatment (A3) Baseline (A4) Treatment (A5) 
* A = Assessment Time 
Appendix K 
Subiective Units of Distress Scale 
Day: 
Date: 
ERP exercise: Exposure 
: Response Prevention 
Ratinq 
Appendix L 
Cognitive Distortions 
1. All-or-None Thinking: You see things in black and white categories. 
If your performance falls short of perfect, you see yourself as a total 
failure. 
Example: "I have a blemish, my whole face is ruined." 
2. Overgeneralization: You see is single negative event as a never- 
ending pattern of defeat. 
Example: "Heishe doesn't like me, I'll never get a date." 
3. Mental Filter: You pick out a single negative detail and dwell on it 
exclusively so that your vision of reality is darkened, like a drop of ink that 
discolors the entire contained of water. 
4. Disqualifying the Positive: You reject positive experiences by 
insisting the "don't count" for some reason or another. In this way you 
can maintain a negative belief even thought it is contradicted by everyday 
experiences. 
Example: When someone compliments your appearance, you think, "Oh 
he's just trying to be nice." Or "I did well on this test, but it was just luck." 
5. Jumping to Conclusions: You make a negative interpretation even 
thought there are no definite facts that convincingly support your 
conclusion. This includes mind-reading (concluding that someone is 
reacting negatively to you without actual evidence) and fortune-telling 
(anticipating that things will turn out badly and mistaking your prediction as 
fact). 
Example: "He didn't say hello. He must think I'm ugly." 
Example: "If I ask her out, She'll laugh in my face. I know it." 
6. Magnification or Minimization: You exaggerate the importance of 
things not done well and minimize the importance of those done well. 
7. Emotional Reasoning: You assume that your emotions reflect the 
way things really are. 
Example: "I feel guilty, so I must have done something wrong." 
Example: "I feel sad, my life must be awful." 
8. Should Statements: You try to motivate yourself with "shoulds," 
musts," and "oughts." The emotional consequences of not complying with 
these self-imposed demands is guilt. When shoulds are directed at 
others, anger, frustration, and resentment results. 
Example: "I should get up at 5 3 0  am and exercise before work." 
Example: "I must lose 10 pounds before the summer." 
Example: "I shouldn't have sucha big nose." 
9. Labeling: Instead of describing the behavior, you attach a negative 
label to yourself or someone else. 
Example: "I am a loser." 
Example: "That guy is a jerk." 
10. Personalization: You incorrectly see yourself as the cause of some 
negative event. 
Example: "It's my fault that everyone left the party early." 
Example: "I ruined the holiday for everyone." 
Appendix M 
Daily Thought Diarv 
Situation: 
Describe the actual event leading to the unpleasant emotion. 
Emotion: 
Specify the emotion and rate the strength of emotion from 1-1 00. 
Automatic Thoushts: 
Write the automatic thoughts that preceded the emotion and rate the 
degree of belief in those thoughts from 0-1 00. 
Rational Response: 
Write rational responses to the irrational automatic thoughts and rate the 
degree of belief in the rational statements from 0-100. 
Appendix N 
Visual Inspection Criteria 
The following guidelines outlined by Parsonson and Baer (1 978) 
were utilized in the visual analysis of the daily data. The first set of 
guidelines addresses variability in the data. First, the stability of the 
baseline will be inspected. Ideally, in order to draw reasonable 
conclusions about the effect of treatment, any trends in the baseline data 
should be in the direction opposite to improvement. Second, variability 
within treatment phases will be examined, with an optimal pattern being 
one of sudden or steady improvement during treatment. Patterns of high 
variability within the treatment phase may indicate the influence of external 
controlling variables. Third, the variability between baseline and treatment 
phases will be inspected, in which experimental control is indicated by 
relatively stable treatment phase data that follows variable baseline data. 
Experimental control is less evident when both treatment and baseline 
phases are variable. Fourth, attention should be paid to the amount of 
overlap between baseline and treatment data points. Although there are 
no set criteria for an acceptable amount of overlap, the most convincing 
treatment effects show less overlap. In addition, overlap of data in the first 
few treatment sessions is more acceptable. 
The second set of guidelines addresses patterns in the data that 
may be indicative of treatment success. First, attention will be paid to any 
changes in overall trend within phases. For instance, in the baseline 
phase, any trend toward improvement in the final data points may raise 
concerns about a natural remission being misconstrued as a positive 
treatment effect. Likewise, any deterioration in the final stages of 
treatment would raise concerns about loss of control of the treatment 
effect. Trends may be determined by drawing a trend line through the 
data points: data in the phase are divided into two groups, the mean of 
each is calculated and plotted, and a straight line is drawn to connect the 
two points. Second, changes in trend, or slope, between baseline and 
treatment phases will be inspected, in which strong indications of 
treatment effects are evidenced by a lack of baseline trend followed by 
downward trend during treatment. Baseline trends toward improvement 
that increase during treatment suggest that the trend would have 
continued in the absence of therapy. Third, changes in level between 
phases will be examined, in which greater and more abrupt changes in 
level are more indicative of treatment effectiveness. 
Appendix 0 
Clinical Siqnificance 
Commonly thought of as a return to normal functioning, clinical 
significance refers to the meaningfulness of change in the client's daily 
life, and is a necessary component of treatment research (Jacobson, 
Roberts, Berns, & McGlinchey, 1999; Kendall, 1997). In order for a 
treatment to be meaningful, it must create a practical and noticeable 
improvement in the daily life of the client or in the lives of significant others 
(Kazdin, 1999; Kendall & Norton-Ford, 1982). The assessment of clinical 
significance is not meant to replace a statistical evaluation. However, 
following support that results are not due to chance, the demonstration of 
clinical meaningfulness is necessary (Chambless & Hollon, 1998; Kendall, 
1999). 
Several methods of assessing clinical significance have been 
proposed in recent years. The reliability change index (RCI) statistically 
assesses whether the degree of change on a questionnaire measure is 
due to chance (Jacobson et al., 1999; Jacobson & Truax, 1991). In order 
to determine whether the amount of change exceeds the margin of 
measurement error, the RCI is calculated by dividing the magnitude of 
therapeutic change by the standard error of the difference score 
(Jacobson et al., 1999). Then, in order to determine clinical significance, 
the RCI is used in tandem with useful cutoff points. Jacobson and Truax 
(1991) have suggested three mathematical cutoff points that distinguish 
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functional from nonfunctional clients. Clinically meaningful improvement 
may be demonstrated when the level of functioning (a) falls two standard 
deviations outside the range of the dysfunctional population, (b) falls two 
standard deviations within the range of the normal population, or (c) is 
statistically more likely to fall in the normal than the dysfunctional range. 
The difficulty with this method concerns the need of norms and variances 
for clinical and nonclinical populations, which are not always available. 
However, the benefit to the RCI and cutoff combination is the inclusion of 
statistical, objective calculation in the determination of clinical significance. 
Clinical significance also may be assessed by statistically 
comparing the treatment group to a normal group, with the goal of treated 
individuals being indistinguishable from the normative sample on the 
relevant measures (Kendall, Marrs-Garcia, Nath, & Sheldrick, 1999). 
Other methods of assessing meaningful change include determining the 
social validity of improvement (Foster & Mash, 1999; Kazdin, 1977; Wolf, 
1978) and whether the change in symptoms improves quality of life 
(Gladis, Gosch, Dishuk, & Crits-Christof, 1999). With these methods, 
assessment largely depends on self-report of factors such as 
interpersonal functioning, quality of work, or leisure activities. However, 
the subjective experience of improved quality of life is a valuable outcome 
and, therefore, could be an indicator of clinical significance. 
The current study assessed clinical significance through two 
approaches. In keeping with past BDD outcome research (Geremia, 
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1997; Neziroglu et al., 1996; Rosen et al., 1995), one criteria for clinically 
significant improvement required the absence of diagnostic criteria for 
BDD as assessed by scores on the BDDE. Secondly, clinically 
meaningful change on questionnaire measures was assessed using the 
statistical approach to clinical significance (Jacobson and Truax, 1991). 
This method was chosen due to its objective ability to determine 
meaningful improvement. Of the three suggested mathematical cutoff 
points described above, two standard deviations below the clinical mean 
was chosen due to the availability of clinical norms and unavailability of 
norms for normal populations on many of the measures. 
Using BDDE Scores To Assess Clinical Significance 
Participants were considered to have met criteria for clinically significant 
improvement once they no longer met criteria for BDD. The BDDE (Rosen & 
Reiter, 1994) is a semi-structured interview designed to aid in the diagnosis of 
BDD. To meet criteria for BDD using the BDDE, individuals must obtain 
particular scores on items indicating symptom intensity in the moderately severe 
to severe range. In keeping with other BDD treatment studies (Geremia, 1997; 
Neziroglu et al., 1996; Rosen et al., 1995), a diagnosis of BDD was considered 
absent once these item scores no longer met the prescribed cutoff. 
Statistical Approach To Clinical Significance 
Clinically significant improvements on questionnaire measures 
were assessed using the statistical approach discussed above (Jacobson 
& Truax, 1991 ). First, the reliability change index (RCI) was calculated to 
determine whether the amount of change exceeded the margin of 
measurement error. For each measure, four RCl's were calculated by 
dividing the magnitude of change from pre- to post-treatment by the 
standard error of the difference score. These four RCl's were computed 
for each participant by using four different post-treatment points as a 
measure of improvement over time. In other words, post-Treatment 1, 
pre-Treatment 2, post-Treatment 2, and Follow-up scores, respectively, 
were subtracted from pre-baseline scores to form the numerator. The 
denominator (i.e., standard error of the difference score) was calculated 
by obtaining the square root of the standard error squared multiplied by 
two. In turn, the standard error of measurement was calculated by 
obtaining the square root of one minus the test-retest reliability of the 
questionnaire. Then, in order for post-treatment improvement to be 
considered beyond the reliability of the measure, the value of the RCI 
must exceed the standard error of measurement for that questionnaire. 
Table 11 presents the values used in determining the RCl's for each 
measure, and Table 12 through Table 16 presents the RCI values for each 
measure. 
Table 0.1. 
Scores Required in the Calculation of Clinical Siqnificance for All Questionnaire 
Measures. 
I BDD I I I I 
I YBOCS- 1 AS I 
Table 0.2. 
YBOCS-BDD Reliabilitv Chanqe Index Scores for All Clients. 
OVlS 
1 
sd 
r-xx 
SE 
s-d iff 
clinical 
mean 
cutoff score 
SADS 
.67 
.71 
.36 
-51 
2.61 
1.27 
7.5 
.88 
2.59 
3.66 
29.3 
14.3 
+ RCI value greater than standard error of measurement 
++ RCI value greater than standard error of measurement and meets criteria for 
2 standard deviations below clinical mean 
BDI-II 
Client 1 
Client 2 
Client 3 
Client 4 
Client 5 
2.4 
.93 
.63 
.89 
5.7 
-90 
Pre- 
Treatment 2 
-.27 
Post- 
Treatment 1 
-1.09 
-3.27++ 
-4.64++ 
1.37 
-2.46 
8.01 
.68 
4.53 
6.41 
9.1 1 
-- 
Post- 
Treatment 2 
-1.09 
11.74 
.93 
3.12 
4.41 
29.45 
6 
Follow-up 
-.82 
-2.73++ 
-3.55++ 
.82 
-2.19 
-2.73++ 
-2.45 
.27 
-3.55++ 
-3.27++ 
-2.45 
.55 
-3.83++ 
Table 0.3. 
AS1 Reliabilitv Chanqe lndex Scores for All Clients. 
Post- 
Client 1 
P re- 
Client 2 
Post- I Follow-up 
Treatment 1 
-.71+ 
Client 3 
-.84+ 
Client 4 
+ RCI value greater than standard error of measurement 
++ RCI value greater than standard error of measurement and meets criteria for 
2 standard deviations below clinical mean 
Treatment 2 
0.00 
-.96+ 
I I I I 
Table 0.4. 
OVlS Reliabilitv Chanqe lndex Scores for All Clients. 
.55+ 
-1.80+ 
Client 5 
I I post- I Pre- I post- I FOHOW-up 
Treatment 2 
0.00 
-.55+ 
.55+ 
-1.27+ 
-.41+ 
-1.41 + 
-1.39+ 
-.71+ 
Client 1 
-1 .lo+ 
-.41+ 
-.29+ -.98+ 
Client 2 
Client 3 
+ RCI value greater than standard error of measurement 
++ RCI value greater than standard error of measurement and meets criteria for 
2 standard deviations below clinical mean 
-.82+ 
-.84+ 
Treatment 1 
-.98+ 
Client 4 
Client 5 
.28 
-1.83+ 
Treatment 2 
-1.40+ 
-1.12+ 
-2.96+ 
-.2 1 
-2.1 I +  
Treatment 2 
.42 
.I 5 
-2.58+ 
-1.40+ 
.28 
-1.27+ 
-.56 
-.99+ 
-.67+ 
-5.95+ 
.43 
-2.25+ 
Table 0.5. 
SADS Reliability Change lndex Scores for All Clients. 
Post- 
Client 1 
Pre- 
Client 2 
Post- I Follow-up 
Treatment 1 
.31 
Client 3 
+ RCI value greater than standard error of measurement 
++ RCI value greater than standard error of measurement and,meets criteria for 
2 standard deviations below clinical mean 
-.47 
Client 4 
Client 5 
Table 0.6. 
BDI-II Reliability Chanqe lndex Scores for All Clients. 
Treatment 2 
-.I6 
-1.25 
-.I6 
0.00 
0.00 
Treatment 2 
-.47 
-1.40 
-.I6 
-1.09 
.I 6 
0.00 
Follow-up 
4.76 
Client 2 
-1.72 
-1.09 
Client 1 
Client 3 
+ RCI value greater than standard error of measurement 
++ RCI value greater than standard error of measurement and meets criteria for 
2 standard deviations below clinical mean 
-1.72 
. I6 
-2.1 8 
Pre- 
Treatment 2 
.68 
Post- 
Treatment 1 
2.72 
-1.36 
Client 4 
Client 5 
-16 
-2.50 
Post- 
Treatment 2 
.9 1 
-1.81 
-1 5 9  
-.68 
-1.36 
-1.36 
-3.85++ 
.68 
-1.36 
-3.63++ 
-1.36 -2.95 
0.00 
-3.85++ 
-1.81 
-2.94 
Secondly, for those comparisons yielding appropriate RCl's, the 
criteria for clinically significant improvement was assessed. Thus, the 
post-treatment scores resulting in a sufficient RCI values were examined 
to determine whether that score was equal to or less than two standard 
deviations below the clinical population mean (Jacobson & Truax, 1991 ). 
Published means, standard deviations, and cutoff scores for the outcome 
measures are presented in Table 1 1 (YBOCS: Phillips et al., 1997; ASI: 
Cash & Labarge, 1996; OVIS: Neziroglu et al., 1998; SADS: Watson & 
Friend,1969; BDI-II: Beck et al, 1996). 
Appendix P 
Summarv of Clients 
Client 1 
Client 1 was a 39 year-old female with a Masters degree in the 
social sciences. She lived with her daughter and partner, and had several 
past therapy experiences for depression. She experienced intense 
preoccupation with the beliefs that her stomach and thighs were extremely 
large, and that her face and body appeared old. The distress generated 
from appearance-related thoughts led to excessive mirror-checking, 
weighing, assessing size through touching, reassurance-seeking, and 
comparing herself to the appearance of other young women in person and 
in magazines, television, and other media sources. At the beginning of 
therapy she avoided many social situations and continually dressed in 
baggy clothing designed to camouflage her stomach and thighs. She also 
reported feeling high levels of depression and continually experienced 
thoughts such as "I am repulsive," "Not only do I not look pretty but I look 
like I belong to another species," "The way I look is so humiliating," and "I 
am ugly and worthless." 
Following the study, she reported that she was able to gain periods of 
insight into her appearance beliefs and sometimes was able to challenge her 
negative thoughts. She stated "I have changed from being all-consumed by my 
thoughts to being able to attack them. I feel like [the thoughts] are external to me 
and under my control." 
Client 2 
Client 2 was a 41 year-old male with a Bachelor's degree in the social 
sciences. At the time of the study, he lived with his parents and was unemployed 
due to extreme concern about his appearance. Past therapy experiences 
included a cognitive-behavioral group for social phobia, and he currently was 
taking an SSRl for chronic depression. Client 2 spent hours each day worrying 
about the configuration of his lips, which he described as ugly and weird. He 
firmly believed that the corners of his mouth turned down dramatically and that 
others would perceive him as ridiculous and ugly. Interestingly, during his early 
adolescence, he had worn an external mouth brace and was teased often by 
peers. In addition, he changed schools several times throughout his childhood 
and adolescence due to his father's many jobs, and experienced difficulty with 
teasing each time. At the time of the study, he experienced intense distress in 
public and social situations, however he forced himself to leave the house, 
believing that isolation would be detrimental to his emotional health. While in 
public, he would constantly engage in behaviors designed to hide his lips or to 
distract others' attention from them (e.g., turning his head, walking sideways, 
hiding behind trees or other large objects, covering mouth with hand, eating, 
taking continuous sips of a drink, talking incessantly to avoid stillness of lips). In 
addition, he experienced thoughts such as "I am so ugly," "I shouldn't expose 
others to this deformity," everyone is looking at me and thinking I am ugly," and "I 
am inferior and inadequate." 
Following the study, he stated that his depression had lifted for the 
first time in years. In addition, he had gained excellent insight into his 
appearance, stating that the real problem was not actually with his lips but 
with his feelings of inferiority. He reported enjoying social situations again, 
and that he felt hopeful about the future. 
Client 3 
Client 3 was a 21 year-old male with a high school education. At 
the time of the study he was unemployed and had discontinued post- 
secondary education due to appearance-related concerns and depression. 
In addition, he lived with his parents following a recent divorce, and stated 
that his wife had left him because he spent too much time obsessing over 
his appearance and asking for reassurance. He reported experiencing 
appearance-related concerns for as long as he could remember, and was 
hospitalized twice in adolescence for suicide attempts related to 
appearance concerns. He had been taking a stable dose of an SSRl for 
several years. 
At the time of the study, Client 3 believed that his face was covered with 
pimples, which caused him to appear disgusting and ugly. Due to intense 
distress, he grew a beard to hide the pimples and avoided most public and social 
situations, spending his days sleeping or watching television in his bedroom. He 
refused to leave his bedroom without applying concealing makeup and, if forced 
to appear in public, would go to great lengths to avoid being seen (e-g., crossing 
the street, hiding behind objects, walking in the opposite direction). Additional 
hours were spent checking his complexion in the mirror and picking at perceived 
173 
pimples. Following treatment, he reported good insight and a notable decrease 
in depression and overall distress. In addition, he shaved his beard, enrolled in 
college classes, and asked a woman out on a date. 
Client 4 
Client 4 was a 44 year-old female with some post-secondary education. 
She reported a varied employment history including secretarial work, homecare, 
and driving 18-wheelers across the country. At the time of the study, she lived 
with her husband and young daughter, and was unemployed due to appearance- 
related concerns and incapacitating symptoms related to anxiety and depression. 
Her home environment was extremely stressful. During the course of the study, 
she had her husband arrested for assault and interrupted her older daughter 
attempting to commit suicide. In addition, she was coping with distress related to 
her own severe childhood abuse perpetrated by her mother. Her distress level 
was so high that the first five minutes of session typically involved her trembling 
and pacing back and forth in the therapy room in an effort to calm herself enough 
to sit down. 
At the time of the study, she reported being extremely distressed with the 
appearance of her face, which she described as repulsive and hideous. In 
particular, she believed that it was not "put together correctly" and that she had 
no right to ever expose others to such a shockingly disgusting sight. Leaving her 
house only to come to session, she wore large sunglasses and a hat pulled down 
over her face. She chose small back roads to drive to session, in order to reduce 
the number of people who might see her face as they drove in the opposite 
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direction. In addition to the avoidance of public situations, she engaged in hours 
of mirror-checking each day. With regard to negative self-statements, she 
frequently had thoughts such as "I am disgusting inside and out," "I am 
unlovable," "People would vomit if they really saw my face." Following 
completion of the study, Client 4 did not report any decrease in symptoms and 
was referred for longer-term treatment. 
Client 5 
Client 5 was a 32 year-old female with a high school education. 
She lived with her husband and was unemployed due to chronic physical 
health difficulties. Appearance-related concerns had developed over the 
past several years, although she recalled always being a socially awkward 
child. She described herself as a "tomboy" in childhood and indicated that 
her mother, whom she described as controlling and manipulative, had 
frequently reprimanded her for not acting sufficiently feminine. Past 
therapy experiences included one course of supportive psychotherapy for 
depression, an assertiveness training course, and an SSRl for 
depression. 
At the time of the study, Client 5 firmly believed that her torso and 
arms were excessively muscular and that she "looked like a boy." 
Although she was approximately five feet and four inches tall with a small 
frame, she reported being extremely embarrassed by her bulky, "wrestler- 
like" appearance. Negative thoughts about her body (e.g., "I look like a 
freak," "I have no right to subject others to this abnormality," "how can [my 
husband] stand to look at me?") led to intense feelings of depression, 
hopelessness, and inadequacy. In turn, she seldom left the house, even 
to check the mailbox, and dressed in very baggy clothing in order to 
camouflage her muscles from her husband. If her husband's friend 
dropped by to visit, she would run to the bathroom and stay there until the 
visitor had left. Following treatment, she stated that she wore more form- 
fitting clothing around her house and that the improved insight regarding 
appearance had led to a higher quality relationship with her husband and 
greater self-confidence. During the last session, she stated "Some days I 
did not want to be. Now life is good." 
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